Effect of Bcl-2 on the cellular response to oxidative stress by Cox, Andrew Graham
 
 
 
 
Effect of Bcl-2 on the 
cellular response to 
oxidative stress  
 
 
 
 
 
 
 
Andrew Graham Cox 
 
 
 
 
 
 
A thesis submitted in partial fulfilment of the  
Requirements for the degree of  
Master of Science of Biochemistry 
at the 
 University of Canterbury 
 
 
 
 
 April 2006 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Abstract 
 
 
Exposure of cells to hydrogen peroxide (H2O2) can cause oxidative damage to cellular 
constituents including lipids, protein, and DNA. At elevated concentrations, H2O2 can 
trigger cell death by apoptosis or necrosis. Apoptotic cell death can be prevented by 
overexpression of the oncoprotein Bcl-2. The exact mechanism by which Bcl-2 blocks 
cell death is controversial. Some researchers believe that Bcl-2 possesses antioxidant 
properties that protect cells from apoptosis. The purpose of this thesis was to assess 
oxidative stress and apoptosis following H2O2 exposure in Jurkat T cells 
overexpressing Bcl-2. One of the major objectives was to ascertain whether or not 
Bcl-2 overexpression elevated the antioxidant capacity of Jurkat T cells to provide 
protection from oxidant-induced cell death.  
 
H2O2 treated Jurkat cells became apoptotic at moderate levels of oxidant (25-100 μM 
H2O2), and necrotic at higher doses (>200 μM H2O2). Bcl-2 overexpression prevented 
caspase activation and cell death at the apoptotic doses of H2O2, but not the necrotic 
doses. Caspase inhibition studies demonstrated that Bcl-2 overexpression provided a 
greater level of resistance from H2O2-induced cell death than the broad-spectrum 
caspase inhibitor z-VAD.fmk. 
 
A systematic study was carried out examining the antioxidant status of Jurkat cells 
overexpressing Bcl-2. Several Bcl-2 transfectants were utilised for the study, so that 
any differences seen could be correlated to the level of Bcl-2 expression. Surprisingly, 
there were no statistically significant differences among the Bcl-2 transfectants for 
any of the antioxidant enzymes.  
 
Jurkat cells overexpressing Bcl-2 exhibited the same level of oxidative damage to 
lipids and protein in response to H2O2 exposure as the parental Jurkat cells. 
Interestingly, Jurkat cells overexpressing Bcl-2 continued to grow in culture after 
H2O2 exposure, despite harboring damage to cellular constituents. Consistent with 
these results, H2O2 treated Jurkat cells overexpressing Bcl-2, which failed to undergo 
apoptosis, were more prone to genomic instability.  
 
Together, these findings suggest that Bcl-2 overexpression protects Jurkat cells from 
H2O2-induced cell death by blocking apoptosis. Jurkat cells overexpressing Bcl-2 
were no better at detoxifying oxidants and showed the same level of oxidative damage 
following H2O2 exposure. As a result, the overexpression of Bcl-2 considerably 
enhanced the mutagenicity of H2O2.  
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Chapter 1: Introduction 
       
 
The oxidant H2O2 can damage cellular constituents and trigger the programmed cell 
death pathway apoptosis. Apoptosis can be blocked by overexpression of the 
oncoprotein Bcl-2. Many investigators believe that Bcl-2 also possesses antioxidant 
properties that protect cells from oxidative stress. The purpose of this thesis was to 
examine the consequences of H2O2-mediated oxidative stress in Jurkat T lymphocytes 
overexpressing Bcl-2, and to determine if antioxidant properties of Bcl-2 contribute to 
the protection that Bcl-2 provides from oxidative stress. 
 
 
1.1  Oxidative stress  
Oxidative stress arises from a cellular imbalance between oxidants and antioxidants 
culminating in oxidant generation which exceeds the detoxification capacity of the 
cell (Finkel and Holbrook 2000). Reactive oxygen species (ROS), produced 
endogenously or derived from external sources, pose a threat to most major cellular 
substituents including lipids, protein and DNA (Figure 1.1). Oxidative damage can 
inhibit proliferation (growth-arrest), cause premature ageing (cellular senescence), 
and in some circumstances trigger cell death (Chandra et al. 2000; Finkel 2003). 
Aerobic cells have evolved to cope with the toxicity of ROS by utilizing a range of 
enzymatic and non-enzymatic antioxidants (Ames et al. 1993; Halliwell 1996). These 
antioxidants function by either scavenging or repairing damage caused by ROS.  
 
The two major ROS produced endogenously are superoxide (O2-.) and hydrogen 
peroxide (H2O2). Although there are many endogenous sources of ROS, by far the 
majority (~90%) is produced by the mitochondrial electron transport chain during 
oxidative phosphorylation (Balaban et al. 2005). O2-., formed via the incomplete 
reduction of molecular oxygen during mitochondrial respiration, dismutates 
spontaneously and via an enzyme-catalysed reaction to form H2O2. While O2-. and 
H2O2 may cause damage in some circumstances, their effects are more dramatic in 
combination with other ROS (Beckman and Koppenol 1996; Halliwell 1996). For 
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instance, O2-. can combine with endogenous nitric oxide (NO.) to form peroxynitrite 
(ONOO-.), a reactive nitrating agent (Beckman and Koppenol 1996).  Similarly, H2O2 
can participate in Fenton chemistry by reacting with free iron (Fe2+) to produce the 
hydroxyl radical (OH-.), a very reactive and indiscriminant oxidant (Wardman and 
Candeias 1996).  
 
 
 
Figure 1.1: ROS can cause oxidative damage to cellular components (Finkel and 
Holbrook 2000).  
 
1.1.1 Consequences of oxidative stress in cultured cells  
Lipid peroxidation 
Lipids are particularly susceptible to oxidation due to their abundance at sites of ROS 
generation (Niki et al. 2005). Lipid peroxidation is a process initiated by the 
abstraction of a hydrogen atom from a fatty acid chain (LH) by a radical (R.). The 
resulting carbon centred lipid radical reacts immediately with oxygen to form the 
peroxyl radical (LOO.), which can propagate lipid peroxidation by abstracting a 
hydrogen atom from neighboring lipids (Porter et al. 1995).  
 
1. Initiation   LH + R. → L. + RH 
2. Propagation   L. + O2 → LOO.  
3. Propagation  LOO. + LH→ LOOH + L. 
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The chain reaction results in the accumulation of lipid hydroperoxides 
(LOOH), which perturb membrane structure and participate in further redox reactions. 
This includes the formation of toxic aldehyde products such as malondialdehyde 
(MDA) that cause further damage to the cell by modifying proteins (Esterbauer et al. 
1991).  
 
Oxidation of proteins 
The oxidation of proteins can severely compromise cellular function by inactivating 
enzymes, compromising structural proteins and disrupting protein-protein interactions 
involved in signal transduction pathways (Martinez-Sanchez et al. 2005). One of the 
most widely studied products of protein oxidation are protein carbonyls (Berlett and 
Stadtman 1997). Protein carbonyls can be formed by the oxidation of lysine, arginine, 
proline, and threonine residues. In addition, carbonyl moieties can be introduced into 
proteins by electrophilic modification, with aldehydes formed during lipid 
peroxidation (Figure 1.2) (Esterbauer et al. 1991).  
 
HN
N
H
NH2
O
O O
HN
N
H
O
N
O
Protein-bound lysine
Protein-bound carbonylMalondialdehyde
R'
R'
R
R
 
 
Figure 1.2: Example of protein carbonyl formation. Reactive aldehydes such as 
malondialdehyde can react with basic residues to form protein carbonyl derivatives 
(Esterbauer et al. 1991). 
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Cysteine residues (Cys-SH) within proteins are highly sensitive to changes in the 
redox status of the cell (Finkel 2000; Ghezzi 2005). H2O2 can oxidise cysteine 
residues within proteins to form sulfenic acids (Cys-SOH), sulfinic acids (Cys-SO2H), 
intra- and inter-disulfides or mixed disulfides with glutathione (Jacob and Sies 2003) 
(Figure 1.3).  
 
HN CH C
CH2
R''
O
SH
HN CH C
CH2
R''
O
S
HN CH C
CH2
R''
O
S
H2O2 H2O2
OOH
OH
Protein-bound
cysteine
Sulfenic acid Sulfinic acid
Intramolecular disulfide
Intermolecular disulfide
GSH-mixed disulfide
Glutathione (GSH)
Protein-SH
Protein-SH
R RR
S S
Protein
S SProtein Protein
S S ProteinGlutathione
 
 
Figure 1.3: Protein thiol oxidation products. ROS such as H2O2 react with protein 
thiols to form a variety of oxidised thiol derivatives (Ghezzi 2005). 
 
It has become increasingly apparent that cells are able to use the oxidation of reactive 
cysteine residues to sense changes in ROS levels in their immediate environment 
(Cross and Templeton 2004; Forman et al. 2004). This phenomenon was first 
characterised in bacteria, where a cysteine residue in the OxyR transcription factor is 
oxidised, leading to activation and increased transcription of antioxidant and repair 
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enzymes (Zheng et al. 1998; Choi et al. 2001; Lee et al. 2004). A variety of other 
redox-sensitive thiol proteins have been discovered in eukaryotes (Li and Karin 1999; 
Delaunay et al. 2000; Dinkova-Kostova et al. 2002; Wood et al. 2003a), although 
their importance in the cellular responses to oxidative stress is unclear. The factors 
responsible for the greatly increased reactivity of some cysteines also remain to be 
completely characterised, but one important factor is the presence of positively 
charged residues in the immediate vicinity that lower the pKa of the cysteine 
sulfhydryl (Wood et al. 2003a; Forman et al. 2004).  
 
DNA damage  
ROS can severely damage DNA to form oxidised derivatives such as 8-hydroxy-
deoxyguanosine (8-oxo-dG) (Halliwell and Aruoma 1991; Valko et al. 2004) (Figure 
1.4). Under normal circumstances, these defects are repaired by the DNA base 
excision repair pathway. However, in cells exposed to chronic oxidative stress, 8-oxo-
dG accumulates. 8-oxo-dG codes for adenosine instead of cytosine, initiating a 
deleterious G→T transversion mutation (Klein et al. 1992).  
 
N
NN
N
NH2
O
HOH
HH
HH
HO
N
NN
H
N
NH2
O
HOH
HH
HH
HO
O
Deoxyguanosine 8-oxo-deoxyguanosine
ROS
 
 
Figure 1.4: DNA base oxidation. ROS oxidise DNA to form 8-oxo-deoxyguanosine 
(Halliwell and Aruoma 1991). 
 
In addition to modifying nucleosides, ROS can attack the DNA backbone, forming 
DNA double strand breaks (DSBs) (Jackson et al. 1998). Left unaided, DSBs trigger 
chromosomal translocations and promote persistent genomic instability, a process 
characterized by the formation of chromosome aberrations that are transmissible to 
daughter cells (Zhivotovsky and Kroemer 2004). 
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1.1.2 Cellular responses to oxidative stress 
The cellular response to ROS is largely dependent on the level of oxidant exposure. 
Low levels of H2O2 activate gene expression to induce proliferation, presumably by 
acting as a second messenger molecule in mitogenic signaling pathways (Burdon et 
al. 1996; Finkel 2000). Elevated levels of oxidant can activate a number of stress 
pathways, including temporary growth arrest, cellular senescence, apoptosis and 
necrosis (Davies 1999).   
 
Cells exposed to a moderate level of oxidative stress can become temporarily growth-
arrested (Davies 1999). Cells downregulate the transcription of housekeeping genes 
and activate the transcription of stress-responsive genes designed to repair oxidative 
damage (Wiese et al. 1995; Crawford et al. 1996; Li and Karin 1999). Hence, 
temporary growth arrest is an adaptive response that allows cells to cope with 
moderate oxidant exposure. 
 
Cellular senescence is a stress-responsive program activated in response to a high 
level of oxidative stress, and is designed to block the replication of damaged cells 
(Sherr and DePinho 2000). ROS can trigger cellular senescence in a p53-dependent 
pathway mediated by DNA damage (Ben-Porath and Weinberg 2005). Senescent cell 
populations disregard mitogenic signals and become permanently growth arrested. In 
the growth-arrested state, morphological and metabolic changes occur that parallel 
changes seen in aging cells (Campisi 1996; Sherr and DePinho 2000).  
  
If oxidative stress results in extensive irreparable damage to the cell, a cell death 
program called apoptosis is activated (Green 1998; Finkel 2003). Apoptotic cells 
exhibit common morphological changes including cell shrinkage, nuclear 
condensation and membrane blebbing (Kerr et al. 1972). These morphological 
characteristics are associated with the activation of intracellular proteases known as 
caspases (Thornberry and Lazebnik 1998). Apoptosis is an energetic process requiring 
ATP, and can be activated and modulated by perturbations in the redox tone of the 
cell, as many factors involved are highly redox-sensitive (Hampton and Orrenius 
1998; Cross and Templeton 2004). Cells exposed to extremely high or sustained 
levels of ROS undergo a caspase-independent form of cell death known as necrosis 
(Chandra et al. 2000; Zong and Thompson 2006). The necrotic pathway is 
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characterized by a loss of membrane integrity that causes the release of noxious 
oxidants, which promote inflammatory responses in surrounding tissue. Apoptosis 
cannot occur under extreme oxidative stress because there is a loss of cellular ATP 
(Eguchi et al. 1997) and the caspases contain an active site cysteine residue that is 
susceptible to oxidative inactivation (Hampton and Orrenius 1997; Hampton et al. 
2002). 
 
1.1.3 Involvement of ROS in carcinogenesis and tumour development 
There is mounting evidence that ROS play a major role in the initiation of diseases 
such as cancer (Behrend et al. 2003; Storz 2005). The incidence of cancer rises 
sharply with age, suggesting that age-related defects at the cellular level might be 
responsible for increased susceptibility to this disease (Finkel 2005). It is generally 
accepted that mitochondrial respiratory function declines with ageing, leading to an 
increase in ROS production, which in turn, promotes further damage (Balaban et al. 
2005). Many believe that the “vicious cycle” of ROS production, caused by 
mitochondrial dysfunction, is a primary factor involved in the age-related increase in 
susceptibility to cancer. In support of this theory, mice with impaired antioxidant 
defence, have an increased rate of spontaneous tumour formation (Neumann et al. 
2003). Furthermore, many studies have documented that antioxidant supplementation 
can prevent the formation of tumours in cancer-prone mice (Schubert et al. 2004; 
Sablina et al. 2005), reinforcing the view that ROS drive tumour progression (Sablina 
et al. 2005). Enhanced ROS production can promote tumourigenesis by providing a 
mutagenic environment that facilitates genomic instability (Vafa et al. 2002; Sablina 
et al. 2005). In addition, ROS can promote malignant transformation towards a 
metastatic phenotype (Radisky et al. 2005). Consistent with the role of ROS in tumour 
development, established cancer cells have been shown to produce elevated levels of 
ROS, including H2O2 (Szatrowski and Nathan 1991). 
 
1.1.4 Cellular defence against oxidative stress 
Direct antioxidant scavengers 
Antioxidants that directly scavenge ROS form the first line of defence against 
oxidative stress. Some antioxidant scavengers, including vitamin C and E, are not 
synthesized by humans and therefore need to be obtained from the diet. Vitamin C 
(ascorbate) scavenges ROS by donating an electron to form the relatively unreactive 
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semidehydroascorbate radical, which is regenerated to ascorbate and 
dehydroascorbate via a disproportionation reaction (Kojo 2004). Vitamin E (α-
tocopherol) is a hydrophobic antioxidant that protects the cellular membrane from 
lipid peroxidation by scavenging lipid peroxyl radicals (Singh et al. 2005). The 
resultant α-tocopherol radical can be recycled to its original form by vitamin C 
(Halliwell 1996).  
 
Superoxide dismutase (SOD) is an enzymatic antioxidant that forms the cornerstone 
for defence against ROS (Fridovich 1995). As the name implies, its function is to 
catalyse the dismutation of O2-. to H2O2. The two major isoforms of SOD (CuZn-SOD 
and Mn-SOD) reside in distinct cellular compartments. CuZn-SOD (SOD1) is a 32 
kDa cytosolic protein that relies on zinc to stabilise the enzyme and the redox 
chemistry of copper (Cu2+) to catalyse superoxide dismutation. Mn-SOD (SOD2) is a 
40 kDa tetrameric protein that resides exclusively in the mitochondrial matrix 
(MacMillan-Crow and Cruthirds 2001). Although Mn-SOD is less abundant than 
CuZn-SOD, its importance is demonstrated by the finding that Mn-SOD deficient 
mice die within 2 weeks of birth (Li et al. 1995). 
 
One of the predominant enzymes involved with decomposing H2O2 is catalase. 
Catalase is a heme-based protein that decomposes two molecules of H2O2 to form 
water and oxygen (Aebi 1984). The first molecule of H2O2 reacts with the heme in 
catalase to form compound 1, which can then react with a second molecule of H2O2 to 
regenerate the active form of catalase. 
 
Thiol-dependent antioxidants 
Most proteins rely on cofactors such as transition metals and flavins to catalyse redox 
chemistry. In contrast, cysteine and selenocysteine residues can endow proteins with 
the capacity to participate in a variety of redox reactions (Jacob and Sies 2003). The 
reactivity of cysteine and selenocysteine is exploited in numerous antioxidants 
including glutathione, thioredoxin, glutaredoxin, thioredoxin reductase, glutathione 
peroxidase, and the peroxiredoxins. 
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Glutathione (GSH) is a tripeptide (γ-glutamyl-cysteinyl-glycine) that plays a major 
role in maintaining the redox balance of the cell (Sies 1999). It is the most abundant 
non-protein thiol in the cell by several orders of magnitude. GSH can scavenge ROS 
directly or act as a co-factor for enzymatic defenses. The oxidised form of glutathione 
can be regenerated in a NADPH-dependent manner by glutathione reductase. 
Thioredoxin (Trx) is a low molecular weight protein with a conserved Cys-X-X-Cys 
motif that catalyses the reduction of protein disulfides (Burke-Gaffney et al. 2005) 
(Figure 1.5). Thiol exchange reactions performed by Trx result in the formation of an 
intramolecular disulfide, which can be resolved by thioredoxin reductase. The related 
protein, glutaredoxin (Grx), utilises the reducing power of GSH to catalyse disulfide 
reduction (Fernandes and Holmgren 2004) (Figure 1.6A). In mammalian cells, there 
are two isoforms of Trx and Grx, one of which is cytosolic, whilst the other resides in 
mitochondria (Vlamis-Gardikas and Holmgren 2002). 
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Figure 1.5: Thiol exchange reactions of the thioredoxin pathway. Thiol transfer 
reactions involving thioredoxin and thioredoxin reductase drive the reduction of 
oxidised thiols (Holmgren et al. 2005). 
 
Thioredoxin reductase (TrxRed) is a selenoprotein that regenerates oxidised Trx at the 
expense of NADPH (Arner and Holmgren 2000). There are several TrxRed isoforms 
(1-3) that provide complementary activity in the cytosol (TrxRed 1 and 3) and 
mitochondria (TrxRed 2). The Trx/TrxRed system provides significant protection 
from ROS by maintaining a thiol rich intracellular environment. The selenocysteine, 
present in the active site, provides a nucleophilic moiety ideal for the enzymatic 
reduction of Trx. Interestingly, the selenocysteine is exposed at the carboxyl terminus 
Chapter 1    
   
of the protein, which enables it to reduce substrates other than Trx such as Grx and 
vitamin C (May 2002). 
 
Glutathione peroxidase (GPx) is a ubiquitous antioxidant enzyme that uses two 
molecules of GSH to reduce H2O2 to H2O (Flohe and Gunzler 1984; Lei 2002) 
(Figure 1.6B). GPx has a selenocysteine in the active site that promotes the 
nucleophilic decomposition of H2O2. Several isoforms of GPx (GPx 1-6) exist that 
differ in their structure and localisation. Gpx 1 resides in the cytoplasm and 
mitochondria, while Gpx 3 is secreted into the circulation. GPx 4 is a unique isoform 
that specifically reduces alkyl hydroperoxides such as lipid hydroperoxides (Imai and 
Nakagawa 2003; Ran et al. 2005). 
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Figure 1.6: Glutathione cellular reduction pathways. Glutathione participates in 
redox reactions with Grx to reduce protein thiols (A), and Gpx to detoxify ROS (B) 
(Sies 1999). 
 
The peroxiredoxins (Prxs) decompose H2O2 by exploiting the reactivity of a 
conserved cysteine residue termed the peroxidatic cysteine (Cys-SpH) (Rhee et al. 
2005a). The active site of Prx contains positively charged residues that lower the pKa 
of the peroxidatic cysteine, stabilising the thiolate anion  (Cys-Sp-). The various 
isoforms of Prx exist in specific subcellular locations such as the cytosol (Prx 1,2 and 
6), the mitochondria (Prx 3), the extracellular space (Prx 4) and the peroxisome (Prx 
5) (Wood et al. 2003b). The Prxs are one of the most highly abundant proteins in the 
cell (around 0.1-0.8% of the total protein), which compensates for their moderate 
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catalytic efficiency (Rhee et al. 2005c). During the catalytic cycle, the oxidised 
peroxidatic cysteine forms a disulfide bond that can be resolved by Trx (Figure 1.7) 
(Nakamura 2005). The Prxs become inactivated in response to high doses of H2O2, 
due to the overoxidation of the peroxidatic thiol (Cys-SpH) to a sulfinic acid (Cys-
SpO2H) (Georgiou and Masip 2003). However, the overoxidised form of 
peroxiredoxin can be slowly reduced in an ATP-dependent pathway involving the 
enzyme sulfiredoxin (Biteau et al. 2003). In addition to its role as an antioxidant, Prx 
regulates H2O2-mediated signaling pathways in the cell (Rhee et al. 2005b). 
Overexpression of Prx enzymes can reduce H2O2 generated in response to cytokine 
receptor activation and modulate signaling downstream of receptor stimulation 
(Zhang et al. 1997; Kang et al. 1998; Kang et al. 2004; Rhee et al. 2005b). For 
example, the mitochondrial isoform of Prx (Prx 3) can modulate apoptotic signal 
transduction by altering the levels of H2O2 present in the mitochondria (Chang et al. 
2004).  
 
Fast Slow 
 
 
Figure 1.7: Catalytic cycle of the peroxiredoxins (figure adapted from Rhee et al. 
2005a).  
 
Indirect antioxidants 
The term antioxidant has evolved to include entities that can indirectly influence the 
antioxidant capacity of the cell. For instance, the trace mineral selenium (Se) is 
viewed as an antioxidant, in light of its integral function as a redox catalyst in 
selenoproteins, such as Gpx and TrxRed (Tapiero et al. 2003). The expression of 
selenoproteins is compromised by a limited selenium supply (McKenzie et al. 2002). 
Hence, selenium can modulate the expression of essential antioxidant defense 
systems. Similarly, metal binding proteins such as albumin, ferritin, transferrin, 
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ceruplasmin, and metallothioneins are viewed as antioxidants by virtue of their ability 
to sequester redox-active transition metals and thereby prevent ROS formation caused 
by Fenton chemistry (Halliwell 1996; Wardman and Candeias 1996). 
 
Electrophilic thiol-modifying agents, such as polyphenols and the isothiocyanates, 
form a novel class of antioxidant that function by activating the expression of 
endogenous antioxidant defenses, termed the phase 2 response (Talalay et al. 2003; 
Keum et al. 2004; Masella et al. 2005). Paradoxically, inducers of the phase 2 
response act by oxidizing or alkylating cellular thiols. The dosage is key; at lower 
doses, such compounds trigger the phase 2 adaptive response, but at higher doses 
these compounds can be potent inducers of apoptosis (Thomson et al. 2006). The 
phase 2 response is mediated by the transcription factor Nrf2 (Chen and Kong 2004). 
When active, Nrf2 translocates to the nucleus where it binds to conserved ARE 
(antioxidant responsive element) sequences in the promoter region of phase 2 genes to 
activate transcription. Under basal conditions, Nrf2 is sequestered in the cytosol by 
Keap1, which is anchored to the actin cytoskeleton. Electrophilic compounds trigger 
the phase 2 response by directly modifying highly reactive cysteine residues in Keap1 
(Dinkova-Kostova et al. 2002). Cysteine modifications in Keap1 cause a 
conformational change to occur that releases Nrf2, allowing it to translocate to the 
nucleus and activate the phase 2 response (Itoh et al. 1999).  
 
Other proteins, such as c-Myc, p53, Rac1, ATM and Bcl-2 have recently been 
proposed to indirectly alter the redox status of the cell (Hockenbery et al. 1993; 
Polyak et al. 1997; Vafa et al. 2002; Reliene et al. 2004; Schubert et al. 2004; Singh et 
al. 2004). In each case, the mechanism by which these proteins alter cellular redox is 
controversial. The antioxidant properties of Bcl-2 are the focus of this thesis.  
 
 
1.2   Bcl-2  
Research on Bcl-2 has increased exponentially since its discovery more than twenty 
years ago. The sustained research effort is due to both the realisation of its central role 
in the regulation of apoptosis, and the association of Bcl-2 with diseases such as 
cancer. Bcl-2 was first identified as a proto-oncogene present at the breakpoint of a 
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chromosomal rearrangement in B cell follicular lymphoma (Pegoraro et al. 1984; 
Tsujimoto et al. 1984; Bakhshi et al. 1985). A cytogenetic analysis of the lymphoma 
cells revealed a distinctive translocation of chromosomes 14 and 18. The t(14;18) 
chromosome rearrangement repositioned the Bcl-2 gene from its normal position on 
chromosome 18 into the vicinity of an immunoglobulin heavy chain intron enhancer 
present on chromosome 14. The resulting translocation caused a transcriptional 
activation of the Bcl-2 gene, and, therefore, an increase in the abundance of the 
oncoprotein (Graninger et al. 1987; Reed et al. 1987; Seto et al. 1988).  
 
Bcl-2 is the founding member of a family of homologous proteins whose interactions 
dictate the fate of a cell (Adams and Cory 1998). The Bcl-2 family is broadly 
categorized into two groups that regulate apoptosis (figure 1.8). The anti-apoptotic 
members of the Bcl-2 family such as Bcl-2, Bcl-xL, Bcl-w, Mcl-1, A1, and CED-9 
promote cell survival. The pro-apoptotic members (Bax, Bak, Bok, Bik, Hrk, Bim, 
Noxa, Bad, Puma, Bmf, EGL-1 and Bid) are activated by apoptotic stimuli and 
promote cell death (Willis and Adams 2005; Liu et al. 2006). The ratio of the two 
antagonising groups determines whether a cell resists or succumbs to an apoptotic 
stimulus (Korsmeyer et al. 1993; Korsmeyer 1999). The high level of redundancy in 
the family is due to the tissue and stimulus specific expression of various Bcl-2 family 
members. Sequence homology between Bcl-2 family members is confined to Bcl-2 
homology (BH) domains, which are known to be important for protein-protein 
interactions between the family members (Hanada et al. 1995).  
 
Since the discovery of Bcl-2, homologues have been found in lower eukaryotes such 
as nematodes (Caenorhabditis elegens) (Hengartner and Horvitz 1994), fruit flies 
(Drosphila melanogaster) (Quinn et al. 2003), and mosquitoes (Anopheles gambiae) 
(Igaki and Miura 2004), illustrating the likelihood that Bcl-2 function is conserved 
throughout metazoan evolution. Bcl-2 homologues are present in both Epstein-Barr 
virus (EBV) (Henderson et al. 1993) and Kaposi’s sarcoma virus (KSV) (Cheng et al. 
1997; Polster et al. 2004). These animal viruses have been implicated in cancer and 
other disorders. It is likely that EBV and KSV have usurped ancestral forms of the 
Bcl-2 gene from past hosts to exert a survival advantage in infected cells (Parris 
2005). 
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Figure 1.8: The Bcl-2 family of proteins (figure from Adams and Cory 1998). 
 
1.2.1 Role of Bcl-2 in tumourigenesis and cancer 
There has been a long association between Bcl-2 and tumourigenesis. Tumourigenesis 
is a multi-step process involving the progressive transformation of normal cells into 
neoplastic clones via the acquisition of essential traits. At several stages in the 
transformation process, cancer cells can be exposed to a wide variety of apoptosis-
inducing stimuli, such as genotoxicity, uncontrolled proliferation, oxygen and nutrient 
deprivation, and the loss of cell adhesion (Kirkin et al. 2004). Consequently, one on 
the six essential traits of a cancerous cell is the ability to evade apoptosis (Hanahan 
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and Weinberg 2000). Evasion of apoptosis can be fulfilled by the overexpression of 
anti-apoptotic proteins such as Bcl-2. Thus, Bcl-2 represents a unique type of proto-
oncogene that promotes tumourigenesis by preventing apoptosis. 
 
Investigations with transgenic mouse models have provided tantilising evidence for 
the tumourigenic potential of Bcl-2. Pioneering studies by Reed et al. demonstrated 
that when nude mice were injected with Bcl-2 transfected fibroblasts, they developed 
tumours with transformed morphology (Reed et al. 1988). Similar studies were 
performed using Bcl-2-Ig fusion transgenic mice that mimicked the chromosome 
translocation present in follicular lymphoma (McDonnell et al. 1989; McDonnell and 
Korsmeyer 1991). The Bcl-2-Ig transgenic mice displayed an increase in the survival 
of B cells, but otherwise no ill effects(McDonnell et al. 1989). However, after a long 
latency period, the B cells become malignant and the transgenic mice develop diffuse 
large B-cell lymphomas (McDonnell and Korsmeyer 1991). The phenotype of the 
Bcl-2-Ig transgenic mice reflects the stages of follicular lymphoma, in which non-
threatening lymphadenopathy can exist for years before transforming to a more 
aggressive form of the disease. A recent report using conditional Bcl-2/Eu-Myc 
transgenic mice has verified that apoptotic evasion is essential for the maintenance of 
leukemia (Letai et al. 2004). The transgenic mice used in the study developed 
lymphoblastic leukemia with pronounced genomic instability. However, when Bcl-2 
was downregulated in the transgenic mice, the leukemic cells became apoptotic, 
leading to tumour remission and a significantly prolonged survival. Collectively, these 
data suggest that tumourigenic cells constantly convey death signals that are blocked 
by Bcl-2 overexpression (Letai 2005b; Letai et al. 2005).  
 
The overexpression of Bcl-2 has been associated with many forms of cancer including 
B cell lymphoma (Tsujimoto et al. 1985), acute lymphoblastic leukemia 
(CoustanSmith et al. 1996), gastric cancer (Ayhan et al. 1994), colorectal carcinoma 
(Ayhan et al. 1994), and prostate cancer (Krajewska et al. 1996). The overexpression 
of Bcl-2 in such cancers can render tumour cells resistant to radiotherapy and 
chemotherapeutic drugs (Green and Kroemer 2005; Reed and Pellecchia 2005). 
Hence, Bcl-2 has been likened to multidrug resistance (MDR) proteins (Reed 1999). 
However, unlike the MDR efflux pumps, Bcl-2 does not protect cells from the 
cytotoxic effects of a drug, it just prevents the resulting cell death from occurring. 
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Naturally, given its oncogenic potential, Bcl-2 has been a target for drug discovery 
(Juin et al. 2004), the assertion being that inhibition of Bcl-2 would remove the anti-
apoptotic status that cancer cells had exploited to resist chemotherapy. To date, a 
range of small molecule inhibitors of Bcl-2 have been shown to sensitise drug-
resistant cancer cells to apoptosis (Wang et al. 2000; Enyedy et al. 2001; Juin et al. 
2004; O'Neill et al. 2004; Letai 2005a; Oltersdorf et al. 2005; Reed and Pellecchia 
2005). The most successful of these, gossypol, is currently in phase 2 clinical trials 
(Pellecchia and Reed 2004; Reed and Pellecchia 2005).  
 
Another approach used to sensitise cancer cells to apoptosis involves inhibiting Bcl-2 
gene expression with nuclease resistant antisense RNA therapy (Green and Kroemer 
2005; Letai 2005b; Reed and Pellecchia 2005). Bcl-2 antisense therapy has been 
shown to enhance apoptosis alone, and in combination with, conventional 
chemotherapeutics in numerous xenograft mouse models of solid tumours and 
haematological malignancies (Cotter et al. 1994; Jansen et al. 1998; Klasa et al. 2000; 
Leung et al. 2001; Hu et al. 2004; Smith et al. 2004; De Cesare et al. 2005). The Bcl-2 
antisense therapeutic, Oblimersen (G3139, Genasense), has had encouraging results in 
the clinical setting, and is currently in phase 3 clinical trials in combination with 
conventional chemotherapeutics for the treatment of chronic lymphocytic leukemia, 
multiple myeloma, non-Hodgkin’s lymphoma and non-small cell lung carcinoma 
(Chanan-Khan 2004; O'Neill et al. 2004; Piro 2004; Rudin et al. 2004; Chanan-Khan 
2005; Tolcher 2005). 
 
1.2.2 Structure of Bcl-2 
Primary structure: Importance for subcellular localisation 
Bcl-2 has four BH domains (denoted BH1, BH2, BH3 and BH4) each of which is 
vital for function (Hanada et al. 1995). All members of the Bcl-2 family share the 
BH3 domain; however, the BH4 domain is only present in the anti-apoptotic members 
of the family (Huang et al. 1998). The primary structure of Bcl-2 reveals the presence 
of a hydrophobic stretch of 19 amino acids at the C-terminus. The hydrophobic C-
terminal domain is thought to form an α-helix that can span the lipid bilayer, thereby 
acting as a transmembrane anchor to target Bcl-2 to internal membranes within the 
cell. Studies have revealed that the majority of Bcl-2 is localised to the mitochondrial 
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outer membrane (Hockenbery et al. 1990; Nguyen et al. 1993); however, a large 
proportion is also present at the endoplasmic reticulum and nuclear envelope 
(Krajewski et al. 1993; Lithgow et al. 1994). Recent studies have shown that Bcl-2 is 
specifically targeted to the mitochondrial outer membrane, via interactions with 
membrane bound scaffolding protein FKBP38 (Shirane and Nakayama 2003). 
Deletion of FKBP38 leads to a redistribution of Bcl-2 and a marked increase in 
apoptosis.  
 
Tertiary structure of Bcl-2 
Structural data on Bcl-2 have been notoriously difficult to obtain due to the 
insolubility of the hydrophobic C-terminal domain and the unstructured nature of the 
loop domain (Petros et al. 2001). Nevertheless, these problems were eventually 
resolved and the solution structure of Bcl-2 was elucidated by NMR spectroscopy 
(Petros et al. 2001) (Figure 1.9). The tertiary structure of Bcl-2 reveals a 
predominantly α-helical protein containing eight α-helices. The two central 
hydrophobic α-helices (α5 and α6) are surrounded by four amphipathic α-helices 
forming a distinctive hydrophobic groove. The BH1-BH3 domains of Bcl-2 form the 
hydrophobic groove whilst the BH4 domain stabilises the entire structure by burying 
hydrophobic residues (Yan and Shi 2005). Site-directed mutagenesis of the BH1 and 
BH2 domains inactivate Bcl-2 (Yin et al. 1994), demonstrating that the hydrophobic 
groove is necessary for Bcl-2 function. A long loop domain, which is devoid of 
secondary structure, exists between α1 and α2 and functions as a regulatory domain 
(Chang et al. 1997).  
 
A conserved Asp-Trp-Gly-Arg (NWGR) sequence in the BH1 domain is important 
for both the structural integrity and function of Bcl-2 (Petros et al. 2004). Studies have 
demonstrated that deletion of this conserved NWGR motif leads to the inactivation of 
Bcl-2 (Hanada et al. 1995). The tryptophan residue (W) in the NWGR sequence 
makes extensive hydrophobic interactions with α7 and α8 locking the BH1 and BH2 
domains together to define the top of the hydrophobic groove. The arginine residue 
(R) in the NWGR sequence provides a positive charge at the top of the hydrophobic 
groove that is essential for the heterodimerisation function of Bcl-2 (Hanada et al. 
1995). 
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Figure 1.9: Ribbon representation (A) and Connelly surface structure (B) of Bcl-2. 
Yellow coloured residues are hydrophobic, while red and blue coloured residues are 
acidic and basic respectively (Figure from Petros et al. 2004). 
 
Structural insights into Bcl-2 function: Pore formation 
Bcl-2 family structures show a surprising homology with bacterial pore-forming 
toxins such as diptheria and colicin. This homology inspired several studies that 
examined the pore-forming ability of Bcl-2 family members (Schendel et al. 1997). 
By analogy to the bacterial toxins, the investigators proposed that the two 
hydrophobic α-helices (α5 and α6) could span the membrane, while the 
amphipathic α-helices assembled above the lipid bilayer like an umbrella. A 
functional pore with an aqueous lumen could, therefore, be envisaged, consisting of 
dimers or oligomers of Bcl-2. Biophysical studies by Schendel et al. (Schendel et al. 
1997) have provided proof of principle using recombinant Bcl-2 in planar lipid 
bilayers to form a functional pore. However, pore formation required a pH lower than 
4, an abundance of anionic lipids in the membrane and a trans-negative membrane 
potential. Such conditions would be difficult to emulate in vivo; therefore, the 
functional significance of pore formation by Bcl-2 is not known. 
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Structural insights into Bcl-2 function: Heterodimerisation 
The predominant function of Bcl-2 is to heterodimerise with pro-apoptotic members 
of the Bcl-2 family. The structural requirements for heterodimerisation have been 
clarified with NMR-derived structural studies on the related protein Bcl-xL (Sattler et 
al. 1997). The solution structure of a Bcl-xL/Bak complex revealed the importance of 
the hydrophobic groove in recognising pro-apoptotic members of the Bcl-2 family at 
the molecular level. The structural data verified that neither the BH1 or BH2 domains 
of pro-apoptotic family members are necessary for heterodimerisation (Chittenden et 
al. 1995). Instead, Bcl-xL interacted specifically with the BH3 domain of Bak. The 
BH3 domain adopts an amphipathic α-helix upon binding via both hydrophobic and 
electrostatic interactions. Conserved hydrophobic residues (Val74, Leu78, Ile81and 
Ile85) present on the BH3 peptide, align within the hydrophobic groove, while 
charged residues (Arg76, Asp83, and Asp84) form electrostatic bridges with 
oppositely charged residues within Bcl-xL (Glu129, Arg139, and Arg100). The need 
for both hydrophobic and electrostatic interactions at the interface was confirmed by 
alanine scan mutagenesis of the BH3 peptide (Sattler et al. 1997). Peptide binding 
studies with Bcl-2 and BH3 peptides have shown similar hydrophobic and 
electrostatic requirements for efficient heterodimerisation (Petros et al. 2001) (Figure 
1.10). 
 
 
Figure 1.10: Heterodimerisation function of Bcl-2. Bcl-2 heterodimerises to the 
“BH3” domain of pro-apoptotic members of the Bcl-2 family (figure from (Petros et 
al. 2004)). 
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1.2.3 Apoptosis and its regulation by Bcl-2 
Pathways of apoptosis 
The two principle modes of apoptosis are termed the extrinsic and intrinsic pathways. 
The extrinsic pathway is mediated by death receptors including Fas (Nagata 1997). 
On ligand binding, Fas receptors oligomerise and recruit cytosolic adapter proteins to 
form the death-inducing signaling complex (DISC), which can activate caspase 8 and 
promote apoptosis (Kischkel et al. 1995; Muzio et al. 1996; Danial and Korsmeyer 
2004). In contrast, the intrinsic or mitochondrial pathway is controlled by members of 
the Bcl-2 family. Multiple signals, including oxidative stress, activate the 
mitochondrial pathway making it the dominant form of programmed cell death (Green 
and Kroemer 2004) (Figure 1.11).  
 
 
Figure 1.11: The mitochondrial pathway of apoptosis (figure adapted from Green 
and Kroemer 2005). 
 
The mitochondrial pathway of apoptosis 
During mitochondrial-mediated apoptosis, pro-apoptotic members of the Bcl-2 family 
become activated and promote mitochondrial outer membrane permeabilisation 
(MOMP). The permeabilisation of the mitochondria releases cytochrome c (cyt c), 
which forms a complex with Apaf-1 and dATP (Liu et al. 1996; Li et al. 1997). The 
cyt c/Apaf-1/dATP complex facilitates a conformational change in Apaf-1, exposing a 
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binding site for the “activator” caspase, procaspase-9. The resulting holoenzyme 
complex, termed the apoptosome, catalyses the auto-cleavage of procaspase 9 into the 
active form (Acehan et al. 2002). Caspase 9, in turn, cleaves and activates the 
“executioner” caspases (caspase 3 and 7). Executioner caspases cleave key proteins in 
the cell at conserved Asp-Glu-Val-Asp (DEVD) sequence motifs (Thornberry and 
Lazebnik 1998). The activation of the executioner caspases generally marks a point of 
no return in the apoptotic pathway (Cohen 1997; Salvesen and Dixit 1997).  
 
In addition to cytochrome c, other pro-apoptotic factors such as AIF, Smac/DIABLO, 
endonuclease G and Omi/HtrA are released from mitochondria (Susin et al. 1999; Du 
et al. 2000; Verhagen et al. 2000; van Loo et al. 2001; van Loo et al. 2002b). 
Smac/DIABLO and Omi/HtrA act by binding, via their amino-termini, to endogenous 
IAPs (inhibitors of apoptosis proteins) (Vaux and Silke 2003). In healthy cells, IAPs 
sequester active caspases, thereby helping to prevent accidental cell death. By 
inhibiting IAP function, Smac/DIABLO and Omi/HtrA promote caspase activation 
(Chai et al. 2000; Verhagen et al. 2002). AIF and endonuclease G promote cell death 
by degrading DNA in a caspase-independent manner (Susin et al. 1999; van Loo et al. 
2001). These apoptogenic factors act synergistically with cytochrome c to promote 
cell death (van Loo et al. 2002a).  
 
Role of BH3-only proteins in apoptosis 
Pro-apoptotic Bcl-2 family members that promote this sequence of events can be 
classified into two groups, the BH3-only proteins (Bid, Bim, Puma, Bad, Bmf, Bik, 
Hrk, and Noxa) and the multidomain proteins (Bax and Bak). BH3-only proteins are a 
structurally diverse group of proteins that become activated in response to death 
stimuli (Willis and Adams 2005) (Figure 1.12). Several BH3-only proteins are 
activated at the transcriptional level by growth factor deprivation (Bim and Hrk) and 
DNA damage (Noxa and Puma) (Oda et al. 2000; Nakano and Vousden 2001; 
Puthalakath and Strasser 2002; Willis and Adams 2005). The remainder of the BH3-
only proteins are activated at the post-translational level. For example, Bmf and Bim 
are activated by detachment from the cytoskeleton in response to anoikis and UV 
radiation (Puthalakath et al. 1999). Bad activation requires dephosphorylation and 
dissociation from the adaptor protein 14-3-3 (Zha et al. 1996). Bid is cleaved by 
caspase 8 in response to death receptor activation (Li et al. 1998). The cleaved form, 
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tBid (truncated Bid), is then myristoylated, facilitating its relocation to the 
mitochondrial membrane (Zha et al. 2000). Bid cleavage allows cross talk between 
the extrinsic and intrinsic pathways of apoptosis. BH3-only proteins act as either 
“activators” or “sensitisers” (Letai et al. 2002; Kuwana et al. 2005). Activator BH3-
only proteins (Bid, Bim and Puma) bind and activate multidomain pro-apoptotic 
members of the Bcl-2 family. In contrast, sensitiser BH3-only proteins (Bad, Bmf, 
Bik, Hrk, and Noxa) work by antagonizing anti-apoptotic members of the Bcl-2 
family such as Bcl-2. 
 
 
 
Figure 1.12: Death-inducing stimuli activate “BH3-only” proteins to promote 
apoptosis (figure adapted from (Willis and Adams 2005)). 
 
Role of multidomain proteins in promoting apoptosis 
The multidomain proteins, Bax and Bak, depend on activated BH3-only proteins to 
promote MOMP. The mechanism by which Bax and Bak function at the molecular 
level is debatable, however there are three major theories. The first theory suggests 
that Bax and Bak can alter the composition of the membrane allowing the formation 
of lipid pores (Basanez et al. 1999). In this model BH3-only molecules activate Bax, 
which promotes a positive membrane curvature and pore formation (Terrones et al. 
2004).  
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The second theory proposes that the Bcl-2 family members regulate a pre-existing 
mitochondrial permeability transition pore (PTP) (Brenner et al. 2000). The PTP 
complex is composed of several mitochondrial proteins including VDAC, ANT, and 
cyclophilin D. Together these proteins form a pore that spans both the inner and outer 
mitochondrial membranes. The opening of such a pore leads to a phenomenon termed 
mitochondrial permeability transition (MPT) (Sharpe et al. 2004). The MPT process is 
characterized by an influx of protons, resulting in mitochondrial swelling and eventual 
membrane rupture. In support of this theory, Bax and Bak have been shown to bind to 
both VDAC and ANT, activating the PTP and triggering MPT (Marzo et al. 1998; 
Shimizu et al. 1999). However, recent studies using cyclophilin D knockout mice 
(CypD-/-) have helped to clarify the importance of the PTP in cell death (Baines et al. 
2005; Halestrap 2005; Nakagawa et al. 2005). Cyclophilin D deficiency prevents the 
formation of the PTP and, therefore, blocks the MPT. CypD-/- fibroblasts are more 
resistant to necrotic triggers of cell death, such as oxidative stress. However, CypD-/- 
and wildtype fibroblasts displayed similar sensitivities to apoptotic triggers. The 
emergent view is that the PTP regulates necrosis, but is not required for apoptotic cell 
death. 
 
The third and most widely accepted theory is that, upon activation, multidomain pro-
apoptotic proteins form de novo pores that cause MOMP (Green and Kroemer 2004). 
The formation of such pores requires the presence of activator BH3-only proteins, in 
order to facilitate translocation of Bax and Bak, to the mitochondria. Once at the 
mitochondria, conformational changes take place that trigger the exposure of the N-
terminal region (Ruffolo and Shore 2003). The exposure promotes the oligomerisation 
of Bax and Bak, leading to the formation of focal clusters on the MOM. Experiments 
using reconstituted systems have demonstrated that Bax and Bak can form 
supramolecular pores large enough to release cytochrome c (Saito et al. 2000; 
Kuwana et al. 2002; Esposti and Dive 2003). 
 
Role of Bcl-2 in preventing apoptosis 
The anti-apoptotic members of the Bcl-2 family play a prominent role in maintaining 
the integrity of the mitochondrial outer membrane in response to cytotoxic insult. 
Studies have demonstrated that Bcl-2 blocks the apoptotic pathway by preventing the 
release of apoptogenic factors such as cytochrome c from the mitochondria (Kluck et 
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al. 1997; Yang et al. 1997). In addition, Bcl-2 blocks upstream events prior to the 
MOMP including Bax/Bak activation, relocalisation, and oligomerisation (Mikhailov 
et al. 2001; Yi et al. 2003). Together, these findings support the hypothesis that Bcl-2 
sequesters BH3-only proteins, preventing the allosteric activation of multidomain pro-
apoptotic proteins that lead to MOMP (Cheng et al. 2001). Hence, the overexpression 
of Bcl-2 can render cells resistant to apoptosis by preventing the conduction of a death 
signal to the death effecter (Letai 2005b; Letai et al. 2005).  
 
1.2.3 Antioxidant function of Bcl-2 
Much of the research performed on Bcl-2 has focused on its role in heterodimerising 
pro-apoptotic members of the Bcl-2 family. However, the involvement of ROS in the 
regulation of apoptosis, led Hockenbery and colleagues to propose that Bcl-2 may 
function as an antioxidant (Hockenbery et al. 1993). As such, the anti-apoptotic 
activity of Bcl-2 may stem in part from its ability to enhance the antioxidant capacity 
of the cell. This theory was supported by the initial observation that Bcl-2 protected 
cells from apoptosis induced by the oxidants H2O2 and menadione (Hockenbery et al. 
1993). In the same study, Bcl-2 overexpression suppressed lipid peroxidation and 
provided a similar level of protection from oxidant-induced cell death as the H2O2 
scavenger NAC. Complementary findings later that year, provided further proof that 
Bcl-2 functioned by preventing the accumulation of ROS (Kane et al. 1993). 
Furthermore, the authors demonstrated that cells overexpressing Bcl-2 had higher 
levels of the antioxidant GSH; thus, providing a mechanism by which Bcl-2 could 
provide antioxidant defense.  
 
The potential for Bcl-2 to function as an antioxidant was confirmed by the phenotypic 
assessment of Bcl-2 knockout mice (Nakayama et al. 1993; Veis et al. 1993). The 
Bcl-2 deficient mice developed pathologies consistent with defects in oxidative 
metabolism. For example, the mice exhibited conditions, such as hypopigmentation 
and polycystic kidney disease, which are associated with chronic oxidative stress 
(Lerchl 1994; Maser et al. 2002). Later studies with Bcl-2 deficient mice revealed 
higher levels of protein carbonyls in the brain, liver and kidneys, suggesting that such 
tissues are exposed to higher levels of ROS (Hochman et al. 1998; Hochman et al. 
2000). In contrast, mice that overexpress Bcl-2 show a marked decrease in the 
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generation of ROS (Bogdanov et al. 1999), further implicating an antioxidant aspect 
to Bcl-2 function in vivo.  
 
Since these early studies, numerous reports have demonstrated that Bcl-2 provides 
protection from oxidative stress (Kowaltowski and Fiskum 2005). In particular, the 
overexpression of Bcl-2 has been shown to decrease the production of ROS in 
response to apoptotic stimuli. For example, several groups have provided strong 
evidence that Bcl-2 overexpression prevents the accumulation of H2O2 in response to 
apoptotic stimuli (Kane et al. 1993; Esposti et al. 1999; Khar et al. 2003). 
Furthermore, Bcl-2 overexpression prevents the accumulation of reactive nitrogen 
species (Lee et al. 2001b), O2-. (Cai and Jones 1998) and OH-. (Amstad et al. 2001) in 
cells exposed to apoptotic triggers. Together, these reports suggest that Bcl-2 
promotes survival by preventing ROS generation in response to death-inducing 
stimuli. 
 
Consistent with these findings, several lines of evidence have shown that Bcl-2 
overexpression protects cellular components such as lipids, protein and DNA from 
oxidative stress. For instance, Bcl-2 attenuates lipid peroxidation induced by a range 
of oxidants (Hockenbery et al. 1993; Fabisiak et al. 1997; Tyurina et al. 1997; Bruce-
Keller et al. 1998; Lee et al. 2001a). In a similar manner, the overexpression of Bcl-2 
reduces the amount of protein carbonyls seen both in vitro (Lee et al. 2001a; Lee et al. 
2001b) and in vivo (Bogdanov et al. 1999). Bcl-2 overexpression can prevent DNA 
oxidation in some cell lines, but not others, suggesting that the antioxidant effect of 
Bcl-2 is cell-type specific (Deng et al. 1999; Lee et al. 2001b; Godley et al. 2002; 
Mandavilli et al. 2005).  
 
Bcl-2 overexpression may provide protection from ROS by upregulating key 
antioxidant enzymes. Bcl-2 overexpression has been shown to increase the activity of 
Cu,Zn-SOD, catalase, and Gpx in various cell lines (Ellerby et al. 1996; Papadopoulos 
et al. 1998; Del Bufalo et al. 2001; Lee et al. 2001b); however, the phenomenon 
appears to be cell specific. For example, SOD and catalase activity were upregulated 
in Bcl-2 transfected PC12 cells but not GT1-7 cells (Ellerby et al. 1996). Likewise, 
Lee and colleagues reported that catalase activity was enhanced in Bcl-2 transfected 
SK-M-NC cells but not NT-2 cells (Lee et al. 2001b). The lack of any consistent 
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changes in antioxidant enzyme activities suggests that this may not be the primary 
mechanism by which Bcl-2 protects cells from ROS.   
 
Several lines of evidence have shown that Bcl-2 overexpression enhances cellular 
redox by causing a concomitant increase in the level of GSH (Kane et al. 1993; 
Ellerby et al. 1996; Mirkovic et al. 1997; Meredith et al. 1998; Voehringer 1999; Lee 
et al. 2001b). The enhanced redox status in Bcl-2 overexpressing cells is associated 
with a resistance to apoptosis. Furthermore, Bcl-2 overexpressing cells can be re-
sensitized to apoptosis by GSH depletion (Mirkovic et al. 1997; Rimpler et al. 1999; 
Armstrong and Jones 2002). These findings suggest that Bcl-2 may modulate 
apoptotic sensitivity through an antioxidant pathway that involves cellular thiols.  
 
The Bcl-2-dependent change in redox status predictably increases the level of free 
protein thiols (Ellerby et al. 1996; Tyurin et al. 1998). An increase in reduced protein 
thiols is of great interest in light of recent data demonstrating that protein thiol 
oxidation can regulate the equilibrium between survival and apoptosis (Cross and 
Templeton 2004). In the generalised model, an increase in reduced thiols promotes 
survival, while specific oxidation of protein thiols leads to apoptosis. Consistent with 
this model, a DNA microarray analysis of Bcl-2 overexpressing cells revealed an 
increase in expression of enzymes involved in maintaining thiol homeostasis 
(Voehringer et al. 2000). Hence, the protective effect of GSH in Bcl-2 overexpressing 
cells may reflect a tendency for a specific protein thiol to remain in the reduced form, 
in spite of apoptotic stimuli that might promote its oxidation.   
 
Recent studies have revealed that the overexpression of Bcl-2 leads not only to the 
elevation, but also the redistribution of GSH, from the cytosol to the nucleus 
(Voehringer et al. 1998). The importance of the nuclear GSH compartmentalisation is 
unknown; however, the authors propose that the redistribution of GSH may alter the 
activity of redox-sensitive transcription factors to promote cell survival.  
 
Recent studies have greatly enhanced our understanding of how Bcl-2 may alter the 
antioxidant capacity when overexpressed in cultured cells (Kowaltowski and Fiskum 
2005). The emerging view is that Bcl-2 overexpression may enhance the antioxidant 
status of cells via an adaptive response. This theory proposes that the overexpression 
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of Bcl-2 increases the volume and structural complexity of the mitochondria 
(Kowaltowski et al. 2002), which in turn affects the dynamics of the electron transport 
chain (Kowaltowski et al. 2000; Kowaltowski et al. 2004). These alterations augment 
the level of NADPH and increase the membrane potential (Esposti et al. 1999; 
Kowaltowski et al. 2000). The Bcl-2 dependent change in mitochondrial bioenergetics 
leads to an increase in the basal level of H2O2 production (Esposti et al. 1999; 
Armstrong and Jones 2002; Kowaltowski et al. 2004). Such findings are in agreement 
with the paradoxical reports that Bcl-2 can function as a pro-oxidant (Steinman 1995; 
Seyfried et al. 2003). The subtoxic increase in mitochondrial ROS may allow Bcl-2 
overexpressing cells to adapt by upregulating antioxidant defenses. 
 
Challenges to the antioxidant hypothesis  
Various studies have challenged the hypothesis that Bcl-2 has an antioxidant function: 
instead, it is argued that Bcl-2 provides protection from apoptosis via a redox-
independent mechanism. Several groups have demonstrated that Bcl-2 can protect 
cells from apoptosis in hypoxic conditions (Jacobson and Raff 1995; Shimizu et al. 
1995). Such conditions would preclude the involvement of ROS and would, therefore, 
suggest that Bcl-2 blocks cell death by a ROS-independent mechanism. Related 
studies have shown that the protection Bcl-2 provides from apoptotic stimuli is 
independent of any alterations in cellular redox (Satoh et al. 1996; Gardner et al. 
1997). Furthermore, the effect of Bcl-2 on both antioxidant enzymes and GSH 
metabolism is cell-line dependent (Ellerby et al. 1996; Schor et al. 2000; Lee et al. 
2001b), arguing against a universal model in which Bcl-2 overexpression enhances 
the antioxidant capacity to promote cell survival. 
 
 
1.3     Thesis Objectives 
 
There are conflicting reports in the literature as to whether or not Bcl-2 acts as an 
antioxidant to augment the redox capacity of the cell, and whether this contributes to 
the anti-apoptotic function of Bcl-2. Many of the studies have been performed with 
only a single Bcl-2 transfected cell line. As such, they fail to provide a clear 
relationship between the level of Bcl-2 expression and the extent to which the redox 
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capacity of a cell is modified. This thesis aims to rectify this deficiency by employing 
a number of Bcl-2 transfectants with varying levels of Bcl-2 expression. The use of 
multiple transfectants for comparison ensures that any differences can be correlated to 
the level of Bcl-2 expression. Consequently, this study aims to determine the primary 
mechanism by which Bcl-2 protects Jurkat cells from H2O2.   
 
The aims of this thesis are: 
 
1) To characterize the ability of Bcl-2 to block cell death in Jurkat cells exposed 
to H2O2 (Chapter 3).  
 
2) To determine the effect of Bcl-2 overexpression on the antioxidant status of 
Jurkat cells (Chapter 4).  
 
3) To assess the extent of oxidative damage in Bcl-2 transfected Jurkat cells 
exposed to H2O2 (Chapter 5).  
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Chapter 2: Materials and Methods 
        
 
 
2.1 Materials  
 
Cell culture materials including RPMI 1640, fetal bovine serum (FBS), penicillin, 
streptomycin, and geneticin were from Gibco BRL, Invitrogen, Auckland, New Zealand.  
 
The detergent compatible (DC) protein assay kit, 40% acrylamide/bis solution 37.5:1 and 
Bio-Spin® 6 chromatography columns were from Bio-Rad Laboratories (Hercules, CA, 
USA).  
 
Rabbit polyclonal antibodies to peroxiredoxin 1-6, glutathione peroxidase 1-4, 
thioredoxin reductase 1 and 2, thioredoxin 1 and 2, glutaredoxin 1 and peroxiredoxin-
SO2H were all from Lab Frontier (Seoul, Korea).  
 
Sheep anti-mouse IgG - horseradish peroxidase, Hybond-PVDF membrane and enhanced 
chemiluminescence (ECL™) Western blotting system were from Amersham Biosciences 
(Buckinghamshire, England).  
 
C-11 BODIPY 581/591, 5-iodoacetamidofluorescein, BenchMarkTM pre-stained protein 
ladder and biotinylated rabbit anti-dinitrophenyl-KLH polyclonal antibody were from 
Molecular Probes (Invitrogen, Auckland, New Zealand).  
 
3[(3-Cholamidopropyl)dimethylammonio]propanesulfonic acid (CHAPS) and Complete™ 
protease inhibitors were from Roche Diagnostics (Manheim, Germany).  
 
Streptavidin-conjugated horseradish peroxidase and TMB+ chromagen were from Dako 
Corporation (Carpentria, CA, USA).  
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The artificial caspase substrate Asp-Glu-Val-Asp-7-amino-4-methylcoumarin (DEVD-
AMC) was from the Peptide Institute Inc (Osaka, Japan).  
 
Mouse anti-Bcl-2 was from Zymed Laboratories (San Francisco, CA, USA).  
 
Human activating Fas antibody was from Upstate Biotechnology (Lake Placid, NY, 
USA) 
 
The histological stain Diff-QuickTM was from Baxter Healthcare Corporation (Miami, 
FL, USA).  
 
The water-soluble tetrazolium dye (WST-1) was purchased from Dojindo Laboratories 
(Kumamoto, Japan).  
 
All other chemicals and reagents were from Sigma Chemical Co (St Louis, MO, USA) 
and BDH Laboratory Supplies (Poole, England). All water was deionised and 
ultrafiltrated using a Milli-Q filtration system.  
 
 
2.2 Cell Culture 
Human Jurkat T lymphoma cell line derived from an acute lymphoblastic leukemia was 
acquired from the ATCC (Rockville, MD, USA) and grown in RPMI 1640 (Gibco BRL 
Life Technologies, New York, NY, USA) supplemented with 10% fetal bovine serum 
(FBS), 100 U/ml penicillin, and 100 μg/ml streptomycin. Jurkat transfectants 
overexpressing Bcl-2 and neo controls were generated in our laboratory by Dr Susan 
Thomson (section 3.2) and grown in RPMI 1640 supplemented with 10% FBS and 315 
µg/ml geneticin. Cells were maintained in a humidified incubator at 37°C and 5% 
CO2/air.  
 
 
2.3 Treatment of cells 
Cultured cells were collected at optimal growth (~0.7-1x106 cells/ml) and resuspended in 
fresh RPMI 1640 supplemented with 10% FBS at a concentration of 1x106 cells/ml (H2O2 
treatment) or 5x106 cells/ml (Fas-treatment). Jurkat cells were transferred into either 6 
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well plates or 24 well plates, depending on the experimental requirements. Cells were left 
to equilibrate for one hour before being treated.  H2O2 was made fresh daily by dilution 
of H2O2 stock solution in PBS. The concentration of H2O2 was determined by using the 
extinction coefficient (ε240 nm = 43600 M-1.cm-1). Fas experiments were carried out using 
250 ng/ml of agonistic Fas antibody. 
 
 
2.4 Morphological assessment of treated cells 
The morphology of treated cells was examined using an inverted phase contrast 
microscope (Olympus Optical Ltd, Tokyo, Japan) fitted with a 35 mm digital camera 
(Canon Powershot). 
 
 
2.5 Cell Viability 
Cell viability was measured with the DNA-intercalating vital dye propidium iodide (PI) 
(Hudson et al. 1969). PI is excluded from viable cells but is rapidly taken up by dead 
cells due to a loss of membrane integrity (Nicoletti et al. 1991). Treated cells (5x105) 
were harvested by centrifugation at 1000 g for 4 min and resuspended in a 5 ml plastic 
tube with 1 ml of PBS containing 5 μg PI. The cell suspension was incubated in the dark 
for 10 min and then 10,000 cells were analysed using a FACSCalibre flow cytometer 
(Becton Dickinson, Mountain View, CA) to determine the percentage of PI-positive cells.  
 
 
2.6 Caspase assay 
Caspase activity within treated cells was determined fluorometrically by following the 
cleavage of DEVD-AMC (Nicholson et al. 1995). Treated cells (5x105) were collected by 
centrifugation at 1000 g for 4 min and frozen down at –80°C until needed.  Frozen pellets 
(containing approximately 5x105 cells) were resuspended in 10 μl PBS and transferred to 
a 96 well plate. Ninety-five μl of caspase buffer (5 mM dithiothreitol, 100 mM HEPES, 
10% sucrose, 0.1% NP-40 and 0.1% CHAPS at pH 7.25) containing 50 µM DEVD-AMC 
was added to the sample and the rate of AMC production (excitation 370 nm, emission 
445 nm) was followed at 37°C with a POLARstar Galaxy fluorescent platereader (BMG 
Labtechnologies Pty. Ltd. Mt Eliza, Australia). 
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2.7 Preparation of cell lysates 
Jurkat and Bcl-2 transfectant cell lysates were prepared by harvesting cells at optimal 
growth (cell concentration = 0.6-0.9x106 cells/ml) and subjecting them to centrifugation 
at 1000 g for 4 min. Cells were washed in PBS and resuspended in extract buffer (40 mM 
HEPES, 50 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% CHAPS, Complete™ protease 
inhibitors, and pH 7.4) at a concentration of 30 μl/106 cells. Lysates were incubated for 
30 min at 4°C with sporadic vortexing. Thereafter, lysates were clarified by 
centrifugation at 12,000 g for 3 min. The resulting supernatant was stored at –80°C until 
required. 
 
 
2.8 Protein assay 
Protein concentrations were determined using the BioRad Detergent Compatible (DC) 
protein assay kit (Bio-Rad Laboratories, Hercules, CA, USA) according to the 
manufacturer’s instructions. A standard curve was obtained by transferring known 
concentrations (0-10 μg) of bovine serum albumin into a microplate along with 2 μl of 
sample lysates. 25 μl of reagent S was added to each well, followed by 200 μl of reagent 
B. The wells were thoroughly mixed and left for 15 min before the absorbances were read 
at 595 nm using a microplate spectrophotometer (MRX microplate reader, Dynatech 
Laboratories).      
 
 
2.9 SDS-PAGE 
Sample lysates were resolved for immunoblotting or fluorescence analysis by 
discontinuous SDS-PAGE (Laemmli 1970). Depending on the experimental procedure, 
20-40 μg (mini-gel) or 50-100 μg (large-gel) of each sample lysate was combined with 
sample buffer (62.5 mM Tris-HCl pH 6.8, 10% glycerol, 2% SDS, 0.025% bromophenol 
blue, and 5% β-mercaptoethanol) at a 2:1 ratio. Samples were loaded onto a 4% stacking 
gel with a molecular weight standard (BenchMarkTM pre-stained protein ladder) and 
resolved with either a 12% or 15% gel in running buffer (25 mM Tris, 192 mM glycine, 
0.1% SDS, pH 8.3) (Table 2.1). Mini SDS-PAGE was performed using the BioRad Mini 
Protean 3 system with a BioRad Powerpack 300 running for 90 min at 150 V. Large 
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format electrophoresis was run overnight on a Protean 2 Xi cell with an Ephortec 3000 
power supply for 20 hrs at 20 mA. 
 
Mini SDS-PAGE (2 gels) Separating Gel Stacking Gel 
Gel % 10% 12% 15% 4% 
Acrylamide (40%  37.5:1) 2.5 ml 3 ml 3.75 ml 1 ml 
Water 5.4 ml 4.9 ml 4.15 ml 6.4 ml 
2 M Tris HCl pH 8.8 2 ml 2 ml 2 ml  
0.5 M Tris HCl pH 6.8 - - - 2.5 ml 
20% SDS 50 ul 50 ul 50 ul 50 ul 
10% Ammonium persulfate (fresh) 50 ul 50 ul 50 ul 50 ul 
TEMED 15 ul 15 ul 15 ul 15 ul 
Large Format SDS-PAGE (2 gels) Separating Gel  Stacking Gel 
Gel % 10% 12% 15% 4% 
Acrylamide (40%  37.5:1) 13.75 ml 15 ml 18.75 ml 2 ml 
Water 29.7 ml 21.75 ml 20.75 ml 12.8 ml 
2 M Tris HCl pH 8.8 11 ml 12.5 ml 10 ml  
0.5 M Tris HCl pH 6.8 - - - 5 ml 
20% SDS 225 ul 250 ul 250 ul 100 ul 
10% Ammonium persulfate (fresh) 225 ul 250 ul 250 ul 100 ul 
TEMED 25 ul 25 ul 25 ul 20 ul 
 
 
Table 2.1: SDS-PAGE gels were made using the standard recipe summarised above. 
 
 
 
2.10 Immunoblot detection of proteins 
Immunoblotting was performed as previously described (Burnette 1981). The protein 
concentration of cell lysates was determined by the DC protein assay. After addition of 
20 μl sample loading buffer (62.5 mM Tris-HCl pH 6.8, 10% glycerol, 2% SDS, 0.025% 
bromophenol blue, and 5% β-mercaptoethanol), protein extracts (20-40 μg) were 
analysed by SDS-PAGE. Proteins were transferred from SDS-PAGE gels to Hybond 
PVDF membranes by Western blotting in blot buffer (25 mM Tris, 192 mM glycine, 10 
% methanol) for 50 min at 100 Volts. The PVDF membranes were blocked in 5% skim 
milk TBST20 (150 mM NaCl, 50 mM Tris-HCl, pH 8.0, and 0.05% Tween 20) for an 
hour before being washed and probed with the appropriate primary antibody in 2% skim 
milk TBST20 overnight at 4°C (Table 2.2).  The next day, the blots were washed 
thoroughly in TBST20 and probed with either HRP-conjugated sheep anti-mouse 
(1:20,000 dilution) or HRP-conjugated goat anti-rabbit (1:20,000 dilution) antibodies in 
2% skim milk TBST20 for an hour. After incubating with the secondary antibody, the 
membranes were washed for the final time in TBST20. Antibodies bound to the PVDF 
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membrane were detected using an enhanced chemiluminescence system (ECL) 
(Amersham Biosciences) and visualized using Kodak film or the Chemidoc FX (BioRad 
laboratories, Hercules, CA, USA). 
 
Antibody Dilution Secondary detection 
anti-Bcl-2 1:20,000 HRP-conjugated sheep anti-mouse  
anti-GAPDH 1:20,000 HRP-conjugated sheep anti-mouse  
anti-actin 1:5,000 HRP-conjugated sheep anti-mouse  
anti-glutathione peroxidase 1 1:2,000 HRP-conjugated goat anti-rabbit  
anti-glutathione peroxidase 3 1:2,000 HRP-conjugated goat anti-rabbit  
anti-glutathione peroxidase 4 1:2,000 HRP-conjugated goat anti-rabbit  
anti-peroxiredoxin 1 1:5,000 HRP-conjugated goat anti-rabbit  
anti-peroxiredoxin 2 1:20,000 HRP-conjugated goat anti-rabbit  
anti-peroxiredoxin 3 1:5,000 HRP-conjugated goat anti-rabbit  
anti-peroxiredoxin 4 1:2,000 HRP-conjugated goat anti-rabbit  
anti-peroxiredoxin 5 1:2,000 HRP-conjugated goat anti-rabbit  
anti-peroxiredoxin 6 1:2,000 HRP-conjugated goat anti-rabbit  
anti-thioredoxin 1 1:1,000 HRP-conjugated goat anti-rabbit  
anti-thioredoxin reductase 1 1:2,000 HRP-conjugated goat anti-rabbit  
anti-thioredoxin reductase 2 1:2,000 HRP-conjugated goat anti-rabbit  
anti-peroxiredoxin-SO2H 1:2,000 HRP-conjugated goat anti-rabbit  
 
Table 2.2: Primary antibody dilutions and requirements for secondary detection. 
 
 
2.11 Superoxide dismutase assay 
Superoxide dismutase (SOD) activity was measured according to the method of Peskin et 
al. (Peskin and Winterborn 2000). The assay uses a superoxide generating system 
(xanthine oxidase and hypoxanthine) to reduce a water-soluble tetrazolium dye (WST-1).  
The reduction of WST-1 was followed kinetically at 450 nm. The presence of SOD in the 
system prevents WST-1 reduction. A dilution series of purified SOD (0-12 ng/ml) and 
sample lysates (0-8 μg) were transferred to a 96-well microplate. Undiluted sample lysate 
aliquots (50 μg) were also transferred to the microplate in order to reveal the maximal 
inhibition of WST-1 reduction. The microplate samples were mixed with 200 μl of a 
freshly prepared reaction cocktail containing 2.5 μl of 1.38 mg/ml xanthine oxidase, 100 
μl of 10 mM WST-1, and 100 μl of 2 mg/ml catalase diluted in 19.3 mls of SOD buffer 
(50 mM sodium phosphate buffer, 0.1 mM DTPA and 0.1 mM hypoxanthine at pH 8).  
The reaction was followed over 5 min by monitoring the change in absorbance at 450nm 
(MRX microplate reader, Dynatech Laboratories). Changes in A450 nm were plotted 
against the amount of sample, to produce a curve describing the inhibition of WST-1 
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reduction in the presence of SOD. The SOD activity of each lysate was determined by 
finding the amount of sample required to inhibit WST-1 reduction by 50% (=1 Unit SOD 
activity). “Cyanide-insensitive” SOD activity was measured in the presence of 5 mM 
sodium cyanide, which was added to the reaction mix just prior to the assay.  
 
 
2.12 Catalase assay 
The catalase activity in sample lysates was determined as previously described (Aebi 
1984), by following the decomposition of H2O2 at 240nm. Ten μg of sample lysate was 
added to 1 ml of 12 mM H2O2 (Initial A240 nm ~ 0.45 au) in a quartz cuvette and the 
reaction was followed on an Agilent UV-Vis spectrophotometer for 2 min to give a linear 
rate of decomposition (au/min). The reaction was stopped with sodium azide (1 mM) to 
confirm that the H2O2 decomposition was catalase-dependent. Decomposition rates were 
calculated from a standard curve, formed by using purified catalase, to determine the 
relative catalase activity (U/mg) of each sample lysate. 
 
 
2.13 Glutathione peroxidase assay 
Glutathione peroxidase activity was measured according to the protocol of Flohe et al. 
(Flohe and Gunzler 1984). The method involves coupling the H2O2-decomposing activity 
of glutathione peroxidase to generate oxidised glutathione, with glutathione reductase, 
which consumes NADPH. The decomposition of NADPH was followed over time on a 
spectrophotometer at 340 nm. Five μg of sample lysate was added to 1 ml of a freshly 
prepared reaction cocktail (48 mM sodium phosphate, 0.38 mM EDTA, 0.95 mM sodium 
azide, 1 mM glutathione, 0.02 mM DTT, and pH 7) in a quartz cuvette. Glutathione 
reductase (3.2 units) and β-NADPH (0.12 mM) were then added to the cocktail and 
mixed by inversion. Finally, H2O2 (250 μM) was combined with the reaction mixture and 
the decrease in absorbance at 340 nm was monitored on an Agilent UV-Vis 
spectrophotometer for 5 min. The ΔA340 nm was used to ascertain the glutathione 
peroxidase activity (U/mg) of each sample. 
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2.14 Thioredoxin reductase assay 
The activity of thioredoxin reductase was measured using minor modifications to the 
method of Arner et al. (Arner et al. 1999). The assay is based on the principle that 
thioredoxin reductase reduces 5,5’-dithiobis (2-nitrobenzoic acid) (DTNB) to 5-thio-2-
nitrobenzoic acid (TNB) in an NADPH-dependent manner. Sample lysates (50 μg) were 
transferred to a microplate and diluted with extract buffer (40 mM HEPES, 50 mM NaCl, 
1 mM EDTA, 1 mM EGTA, 1% CHAPS, Complete™ protease inhibitors, and pH 7.4) to 
a concentration of 1 mg/ml. The microplate samples were mixed with 50 μl of 10 mM 
DTNB and the change in absorbance at 412 nm was monitored for 2 min to give a 
baseline DTNB reduction. After this, 10 μl of 2 mM NADPH was added to the reaction 
mix in order to determine the NADPH-dependent DTNB reduction. The relative activity 
of thioredoxin reductase was equivalent to the difference between ΔA412 nm before and 
after the addition of NADPH. 
 
 
2.15 Determination of thiols  
Free thiol groups in cell lysates were quantified using Ellman’s reagent (DTNB) as 
previously described (Ellman 1958). Fifty μl aliquots of cell lysates (1 mg/ml) and 1-10 
μl aliquots of 1 mM glutathione (1-10 μM) were transferred into a 96-well microplate. 
The samples were mixed with 100 μl of DTNB (200 μM final concentration) in PBS and 
incubated for 15 min in the dark. After this period of time, the absorbances were read at 
412 nm using a MRX microplate reader (Dynatech Laboratories). The concentration of 
thiols was determined by using the extinction coefficient for DTNB (ε412 nm = 13600 M-
1cm-1.). 
 
 
2.16 Ferrous oxidation of xylenol orange (FOX) assay 
The level of H2O2 present in cell culture medium was determined by the FOX assay as 
described by Wolff et al. (Wolff 1994). The FOX assay is based on the principle that 
H2O2 in solution oxidises Fe2+ to Fe3+, which can then complex with xylenol orange to 
form a purple product that can be quantified on a spectrophotometer. Cell culture aliquots 
(10-50 μl) were transferred into 1 ml of FOX reagent (100 μM xylenol orange, 250 μM 
Fe(NH4)SO4, 100 mM sorbitol, 25 mM H2SO4), vortexed and left for 40 min. A standard 
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curve was produced in parallel by mixing 1-5 μl aliquots of 1 mM H2O2 into 1 ml of 
FOX reagent. After incubation, samples were transferred into spectrophotometer cells 
and absorbances were measured at 560 nm on an Agilent UV-Vis spectrophotometer. 
Unknown H2O2 concentrations were determined by comparison to the standard curve.  
 
 
2.17 IAF-labeling of reduced thiols 
Protein-thiols in cell lysates were fluorescently labeled with 5-iodoacetamidofluorescein 
(5-IAF) (Molecular Probes Inc, Eugene, OR). 5-IAF is a fluorescent probe that 
specifically reacts with low pKa thiols to give a fluorescent adduct. Fifty μg of cell lysate 
was incubated with 200 μM 5-IAF for 15 min in the dark. Excess 5-IAF was removed 
from the samples by passing the extracts through Bio-Spin® 6 chromatography columns 
(Bio-Rad Laboratories, Hercules, CA) pre-equilibrated with extract.   
 
 
2.18 IAF-labeling of oxidised thiols 
Reversibly oxidised thiol-containing proteins were fluorescently labeled using a 
technique developed by Baty et al. (Baty et al. 2002; Baty 2004) (Figure 2.1). The 
technique involved blocking reduced protein thiols by alkylation with N-ethylmaleimide 
(NEM). Oxidised thiols were then reduced with dithiothreitol (DTT) and labeled with 5-
IAF. Cell samples (5x106 cells) were harvested by centrifugation at 1000 g for 4 min, 
washed in PBS, then resuspended in 75 μl NEM buffer and incubated on ice for 15 min. 
The cells were solubilised with 1% CHAPS for 15 min and centrifuged at 16,000 g for 4 
min in order to pellet cell debris. The clarified extracts were desalted using Bio-Spin® 6 
chromatography columns equilibrated with extract buffer. The resulting lysates were 
treated with 1 μl of 1 M DTT for 10 min, followed by 2 μl of 10 mM 5-IAF for a further 
15 min in the dark. After incubation, excess 5-IAF was removed from the samples by 
passing extracts through a Bio-Spin® 6 column equilibrated with extract buffer.   
 
 
2.19 Detection of 5-IAF-derivatised protein thiols 
The protein concentration of each 5-IAF labeled lysate was determined before SDS-
PAGE to ensure equal protein loading. 5-IAF labeled samples were resolved by SDS-
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PAGE and then visualized using a BioRad FX fluorescence scanner (excitation λ=488 
nm and emission λ=530 nm, Bio-Rad Laboratories, Hercules, CA, USA). 
 
 
Jurkat cells collected
following treatment
Reduced thiols
blocked
100 mM NEM,15 min
1% CHAPS,
15 min
Centrifuge at 16,000 g for 5 min to remove insoluble material
Pass sample through spin column to remove excess NEM
200 μM IAF 10 min
1 mM DTT, 10 min
Pass sample through spin column to remove excess IAF and salts
Electrophoresis
Scan gels (Ex λ 488 nm, Em λ 530 nm)
Protein assayOxidized thiols
labelled
Method to label reduced thiol proteinsMethod to label oxidized thiol proteins
200 μM IAF and
1% CHAPS,
15 min
Reduced thiols
labelled
Protein assay
 
Figure 2.1: Scheme for the fluorescent labelling of oxidised and reduced thiol proteins 
in treated Jurkat cells (adapted from Baty 2004). 
 
2.20 Coomassie Staining 
To assess the amount of protein loaded into each lane, gels were stained with Coomassie 
blue protein stain. Gels were stained overnight in 0.1% Coomassie Blue G250 containing 
20% methanol. The following day, gels were de-stained with multiple changes of water 
and imaged using a BioRad Fluor-S™ MultiImager (Bio-Rad Laboratories, Hercules, CA, 
USA). 
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2.21 Silver Staining 
SDS-PAGE gels were fixed overnight in 50% ethanol and 10% acetic acid. The next day 
the gels were immersed in oxidising solution (0.2 g/l anhydrous sodium thiosulfate) for 
10 min followed by silver stain (2 g/l AgNO3 + 750 μl/l formaldehyde) for 30 min. 
Thereafter, gels were developed for up to 10 min in developing solution until appropriate 
colour development was reached (60 g/l sodium carbonate, 500 μl/l formaldehyde and 20 
mls oxidising solution) before the reaction was stopped with stop solution (20 g/l sodium 
EDTA). Gels were washed thoroughly between each step with ddH2O and imaged using a 
BioRad Fluor-S™ MultiImager (Bio-Rad Laboratories, Hercules, CA, USA).  
 
 
2.22 Lipid Peroxidation assay 
Lipid peroxidation was detected by utilising the oxidation-sensitive lipophilic probe 
BODIPY 581/591 C-11, as previously described (Drummen et al. 2002). Upon oxidation 
the BODIPY C-11 fluorescence emission peak shifts from ~590 nm (red) to ~510 nm 
(green). Cells were incubated for 30 min in media containing 5 μM BODIPY C-11. After 
incubation, cells were washed in PBS and resuspended in fresh RPMI 1640 supplemented 
with 10% FBS. Resuspended cells were then treated with H2O2 for an hour before being 
analysed by flow cytometry (FACSCalibre flow cytometer, Becton Dickinson, Mountain 
View, CA). The change in intensity of the BODIPY-Green fluorescent signal was used to 
determine the extent of lipid peroxidation.  
 
 
2.23 Protein Carbonyl ELISA 
Protein carbonyls were detected using a microplate ELISA kit developed in our 
laboratory (Buss et al. 1997). The method involved derivatising protein carbonyls with 
dinitrophenylhydrazine (DNP) and adsorbing them to a hi-bond microplate. The DNP-
derivitised protein bound to the microplate was detected using an ELISA based assay. 
Treated cells (1x106) were collected by centrifugation at 1000 g for 4 min and lysed in 40 
μl of PBS by freeze-thaw cycling (Note: detergents and Complete™ protease inhibitors 
interfere with the assay). The protein concentration of sample lysates was determined and 
then 20 μg of protein was transferred to an Eppendorf and dried using a speed-vac 
centrifuge equipped with a refrigerated vapor trap (Savant, Global Medical 
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Instrumentation, Minnesota, USA). The sample pellets were resuspended in 5 μl of PBS 
and derivatised with 15 μl of 0.1 mM DNP for 45 min at room temperature. Carbonyl kit 
standards and quality controls were diluted 10-fold and derivatised in parallel with the 
samples. After incubation, 5 μl of each derivatised sample or standard was mixed with 1 
ml of PBS and immediately transferred (200 μl/well) in triplicate to a hi-bond ELISA 
plate (Corning Costar). The microplate samples were left overnight at 4°C to allow time 
for the protein to adsorb to the well plate. The following day, plates were washed in PBS-
Tween20 (0.05%) and probed with biotinylated anti-DNP (1:1000) in PBS-Tween20 
(0.05%) for 60 min. After washing again with PBS-Tween20 (0.05%), the microplate was 
incubated with streptavidin-conjugated horseradish peroxidase (1:5000) in PBS-Tween20 
(0.05%) for 60 min. After a final wash with PBS-Tween20 (0.05%), 200 μl of chromagen 
(TMB+) was added to each well and incubated until colour developed, at which point, 80 
μl of stop solution (2.5 M H2SO4) was added and the absorbances read at 450 nm using a 
spectrophotometer plate reader (MRX microplate reader, Dynatech Laboratories). The 
carbonyl content of each sample was determined by comparing to the standard curve. 
 
 
2.24 Fluorescence Microscopy 
The lipid peroxidation assay was adapted so that cells could be assessed microscopically. 
The staining methodology was similar; however, stained cells were resuspended at a 
concentration of 5x105 cells/ml in PBS and transferred to a glass slide by 
cytocentrifugation at 300 g for 5 min. The slides were air-dried, fixed in 4% 
paraformaldehyde for 10 min, and coated with Vectorshield mounting medium for 
fluorescence microscopy  (Vector laboratories Inc, Burlingame, CA, USA) before being 
imaged with a fluorescent microscope.  
 
 
2.25 Cell Growth 
Cell growth was monitored by counting cells on a hemocytometer using an inverted 
phase contrast microscope (Olympus Optical Ltd, Tokyo, Japan). Jurkat cells were grown 
for a week and the number of viable cells was determined on a daily basis by using the 
vital dye trypan blue. Each day, 50 μl of cell culture was mixed with 50 μl of 0.5% 
trypan blue and then 10 μl of the mixture was transferred to a hemocytometer for 
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examination. The trypan blue dye specifically stains dead cells but is actively excluded 
from live cells. Cell culture medium was replaced on a daily basis, by pelleting cells and 
resuspending in fresh RPMI 1640 supplemented with 10% FBS, to ensure optimal growth 
conditions. 
 
 
2.26 Cytokinesis Block Micronuclei (CBMN) assay 
The CBMN assay was performed as described by Fenech et al. (Fenech 2000; Fenech et 
al. 2003). The principle behind the assay is to block cells in telophase and scan the 
resulting binucleate (BN) cells for nuclear blebs known as micronuclei (MN). The 
presence of micronuclei in treated cells is a marker of genomic instability. Cells were 
challenged with different doses of H2O2 for 4 hr before being cultured for a further 24 hr 
in media containing 4.5 μg/ml cytochalasin B. The next day, cells were harvested by 
centrifugation at 1000 g for 4 min and resuspended in PBS to a concentration of 5x105 
cells/ml. A 120 μl aliquot of each sample was transferred to a glass slide by 
cytocentrifugation at 500 rpm for 5 min. The slides were air-dried, fixed in absolute 
methanol for 10 min and stained using Diff-Quick. At least 1000 BN cells were counted 
on each slide. Micronuclei were scored (number of micronuclei / 1000 binucleate cells) 
using the criteria previously described under an oil immersion lens (Fenech et al. 2003). 
 
 
2.27 Statistics 
Values are shown as the mean + the standard error of at least 3 individual experiments. 
Correlations are tested for significance using Pearson’s paired comparison of variables. 
All statistical analyses were performed with the software package Sigmastat (Jandel 
Scientific, San Rafael, USA) 
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Chapter 3: Characterising the response 
of Bcl-2 transfected Jurkat T cells to H2O2
            
 
 
3.1 Introduction 
 
H2O2 can elicit a variety of physiological responses including proliferation, temporary 
growth arrest, cellular senescence, apoptosis and necrosis, depending on the dose 
(Davies 1999). Sub-lethal doses of H2O2 have a mitogenic effect, activating gene 
expression to induce proliferation (Burdon 1995). At such doses, H2O2 has been 
proposed to act as a signalling molecule, intentionally generated by NADPH oxidases 
in response to receptor activation (Finkel 2000).  Greater concentrations of H2O2 
stimulate an adaptive response, in which cells become transiently or permanently 
growth arrested (Ben-Porath and Weinberg 2005). The cytotoxic activity of H2O2 has 
been well documented in a variety of mammalian cell types, including the Jurkat T 
lymphoma cell line (Khanna et al. 1998; Chiaramonte et al. 2001; Barbouti et al. 
2002). H2O2 can trigger two distinct forms of cell death, depending on the level of 
oxidant exposure (Hampton and Orrenius 1997, 1998; Chandra et al. 2000; Troyano et 
al. 2003). Intermediate levels of H2O2 exposure are associated with apoptotic cell 
death, while higher doses of H2O2 promote necrosis. The switch from apoptosis to 
necrosis is mediated by both the oxidative inactivation of caspases (Hampton and 
Orrenius 1997; Hampton et al. 2002) and the depletion of ATP (Eguchi et al. 1997). 
ROS, such as H2O2, are thought to promote apoptosis primarily by oxidising cellular 
thiols (Cross and Templeton 2004). In support of this model, antioxidants that 
maintain thiols in their reduced state, including GSH and N-acetyl cysteine, prevent 
apoptosis (Um et al. 1996; Devadas et al. 2003; Cross and Templeton 2004).  
 
Previous studies have shown that Bcl-2 overexpression renders cells resistant to H2O2 
(Hockenbery et al. 1993; Zhong et al. 1993; Ichimiya et al. 1998; Rimpler et al. 1999; 
Ogidigben et al. 2000; Chiaramonte et al. 2001; Lee et al. 2001; Godley et al. 2002; 
Chen et al. 2003). It is not clear whether Bcl-2 protects the cells from H2O2 by 
enhancing the decomposition of H2O2 and the repair/removal of oxidised cellular 
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constituents, or if Bcl-2 prevents cells from undergoing apoptosis induced by 
oxidative stress. Many studies have revealed that Bcl-2 promotes a thiol rich 
intracellular environment resistant to the cytotoxic actions of ROS such as H2O2 
(Rimpler et al. 1999; Lee et al. 2001; Jang and Surh 2004; Kowaltowski and Fiskum 
2005). In contrast, other investigators have found that Bcl-2 provides no protection 
from H2O2-induced cell death (Miyashita and Reed 1992; Lee and Shacter 1997). The 
aim of this series of experiments was to further characterise the protection Bcl-2 
provides against the oxidant H2O2 using transfected Jurkat T lymphocytes. 
 
The major objectives of this chapter were: 
 
1) To determine the concentrations of H2O2 that trigger apoptosis and necrosis in 
Jurkat cells.  
 
2) To determine the effect of Bcl-2 overexpression on H2O2-induced apoptosis 
and necrosis in Jurkat cells.   
 
 
3.2 Experimental approach 
 
The following experiments were performed with a Jurkat T lymphoma cell line 
derived from an acute lymphoblastic leukemia (Gillis and Watson 1980). In order to 
study the effect of Bcl-2 overexpression in cultured cells, a number of Bcl-2 
transfected Jurkat T lymphocytes were generated by Dr Susan Thomson. The cells 
were transfected via lipofection with a pCI-neo vector (Invitrogen, Auckland, New 
Zealand) (Brondyk 1994) containing the BCL-2 cDNA insert (kindly donated by Dr 
Suzanne Cory, Melbourne, Australia) (Figure 3.1). Stable Bcl-2 transfectants were 
selected in geneticin for 4 weeks and cryogenically preserved until required. Neo 
transfectants, carrying the vector without the insert, were generated in parallel to 
provide a set of control transfectants that had undergone the same selection procedure. 
Seven transfectants and the parental Jurkat cell line were chosen for further study. 
Two empty vector Neo transfectants (N1 and N2) and five Bcl-2 transfectants (B1, 
B2, B9, B36 and B38) were utilised. The relative level of Bcl-2 in the transfected cell 
lines was determined by immunoblotting for Bcl-2.  
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Figure 3.1: Diagram of the pCI-neo construct containing the Bcl-2 cDNA insert. 
 
Jurkat cells and Bcl-2 transfectants were treated with Fas or H2O2 and a number of 
cell parameters were measured. Morphological alterations were detected by 
examination of cells under a light microscope. Apoptotic cells activate caspase-3-like 
effector caspases, which cleave various cellular proteins at conserved Asp-Glu-Val-
Asp (DEVD) motifs (Thornberry et al. 1997). Caspase-3 activity was measured by 
monitoring the cleavage of the fluorogenic substrate DEVD-AMC over time 
(Nicholson et al. 1995). Caspases were inhibited by using the pan-caspase inhibitor z-
VAD.fmk (1mM), which directly inhibits the proteolytic activity of the caspases (Slee 
et al. 1996).  Cell viability was measured by using the vital dye propidium iodide (PI) 
and fluorescence-activated cell sorting (FACS) flow cytometry (Nicoletti et al. 1991). 
The membrane integrity of dead cells is compromised, allowing PI to enter and 
intercalate with the major groove of DNA to form a red fluorescent adduct (Hudson et 
al. 1969). PI-stained cells were subjected to FACS analysis to determine the 
proportion of dead cells (PI-positive) in a treated population.  
 
 
3.3 Results 
3.3.1 Determining the relative level of Bcl-2 present in transfected cell lines 
 
The transfectants utilised in this study showed a wide range of Bcl-2 expression 
(Figure 3.2A and B). The B1 and B2 clones had a low level of Bcl-2 expression, 
similar to controls (Jurkat, N1 and N2). Surprisingly, the N1 clones displayed a 9-fold 
increase in Bcl-2 expression, despite being transfected with an empty pCI-neo vector. 
It would appear that the increase in endogenous Bcl-2 expression seen in the N1 clone 
is an artifact of the transfection procedure. This clone was included in subsequent 
analyses to enable comparison between endogenous and vector Bcl-2 overexpression. 
The B36 and B38 clones displayed a moderately elevated level of Bcl-2 expression: 
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about 30-fold greater than controls. The B9 clone showed the greatest increase in Bcl-
2 expression with approximately 60 fold greater expression of Bcl-2 than control 
cells. 
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Figure 3.2: Bcl-2 expression levels in Bcl-2 transfected cells. (A) Illustrative 
Western blot of 3 independent experiments showing Bcl-2 expression in transfectants. 
Transfected cell lysates were prepared from cultures in the exponential phase of 
growth. Samples were then resolved by SDS-PAGE and immunoblotted for Bcl-2. As a 
loading control, all samples were further blotted for GAPDH, a high abundance 
housekeeping protein. (B) Densitometry histogram of Bcl-2 blots. The bands were 
quantified using Quantity-One (BioRad). Values represent the mean + SE of 3 
independent experiments. * Indicates a significant difference (p<0.05) from Jurkat 
cells as determined by a One Way Repeated Measures ANOVA with Bonferroni 
multiple comparison (SigmaStat). 
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 3.3.2  Testing Jurkat and B9 cells against a classical apoptotic stimulus:  
 Fas-mediated apoptosis 
 
Prior to characterising the effect of H2O2 on the Bcl-2 transfectants, Jurkat and B9 
clones were challenged with the agonistic Fas antibody: a classical stimulator of Fas-
mediated apoptosis. Fas-stimulated Jurkat cells displayed typical apoptotic 
morphology, including cell shrinkage and membrane blebbing (Figure 3.3A). 
Furthermore, the apoptotic Jurkat cells experienced a time-dependent increase in the 
activity of the cell death protease caspase-3 (Figure 3.4A). The caspase activity 
peaked with a 25-fold increase three hr after Fas-stimulation. In contrast, the Fas-
stimulated B9 clones exhibited very little apoptotic morphology (Figure 3.3B). 
Consistent with these observations, the B9 clones had a low level of caspase-3 activity 
(Figure 3.4B).  
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B9 + Fas 
 
Figure 3.3: Morphology of Jurkat (A) and B9 (B) cells treated with Fas antibody. 
Cells were treated with 250 ng/ml activating human anti-Fas antibody for 2 hr. 
Images are representative of three independent experiments. 
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Figure 3.4: Caspase-3 activity in Fas treated Jurkat and B9 cells. Jurkat (A) and B9 
(B) cells were treated with and without 250 ng/ml of activating human anti-Fas 
antibody. Cell samples were removed periodically and assayed for caspase-3 
activation by monitoring cleavage of DEVD-AMC. Values represent the mean + SE of 
3 independent experiments. 
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3.3.3  Effect of H2O2 on Jurkat cell viability 
 
The viability of H2O2-treated Jurkat cells was determined for a range of H2O2 
concentrations (Figure 3.5). The Jurkat cells were vulnerable to H2O2, with over 50% 
loss of cell viability (LD50) when challenged with 50 μM H2O2. The entire Jurkat cell 
population was killed by exposure to 200 μM H2O2. The mode of cell death 
(apoptosis or necrosis) could not be determined by this assay, hence it was important 
to examine the cellular morphology and caspase activity when exposed to different 
doses of H2O2. Jurkat cells treated with low concentrations of H2O2 (50 μM H2O2) 
displayed membrane blebbing characteristic of apoptosis (Figure 3.6). However, at 
higher concentrations of H2O2 (200 μM H2O2), the Jurkat cells became swollen and 
necrotic before shrinking at later time points (Figure 3.6). 
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Figure 3.5: Cell viability of Jurkat cells exposed to H2O2. The Jurkat cells were 
challenged with a range of H2O2 doses and incubated for 24 hr. Cells were 
subsequently stained with PI and subjected to FACS analysis to differentiate the 
proportion of PI positive cells in the population. Values represent the mean + SE of 4 
independent experiments. 
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Figure 3.6: Assessing the morphology of Jurkat cells treated with H2O2. Cells were 
treated with H2O2 for 6 hr. Photographs are representative of 3 independent 
experiments. 
 
 
 
3.3.4  Effect of H2O2 on Jurkat caspase activity 
 
To determine the relative level of apoptosis occurring in Jurkat cells at different H2O2 
doses, caspase-3 assays were performed. Caspase-3 activity was monitored 6 hr after 
H2O2 exposure, when cells were showing signs of apoptotic membrane blebbing. The 
Jurkat cells exhibited a sharp increase in caspase-3 activity at the lower doses of 
H2O2, peaking with a 12-fold increase in activity at 50 μM H2O2 (Figure 3.7). Higher 
doses of H2O2 (>400 μM) did not activate caspase-3, indeed caspase-3 activity 
dropped below that seen in untreated cells.  
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Figure 3.7: Caspase-3 activity in H2O2 treated Jurkat cells. Jurkat cells were 
exposed to a range of H2O2 doses for 6 hr.  Cell samples were subsequently removed 
and assayed for caspase-3 activation by monitoring cleavage of DEVD-AMC. Values 
represent the mean + SE of 3 independent experiments. * Indicates a significant 
difference (p<0.05) from untreated cells as determined by a One Way Repeated 
Measures ANOVA with Bonferroni multiple comparison (SigmaStat). 
 
 
3.3.5  Effect of Bcl-2 on H2O2-induced cell death 
 
The Bcl-2 transfectants were exposed to a range of H2O2 doses in order to determine 
the effect of Bcl-2 expression on cell death. The Neo-1 clone displayed a similar level 
of sensitivity to H2O2 as that seen in the parental Jurkat cells (Figure 3.8). The Bcl-2 
transfectants (B2, B36 and B9) had an elevated level of protection against cell death 
following H2O2 exposure. The B2 clones had an intermediate level of resistance, with 
an LD50 of approximately 100 μM. The B36 and B9 clones were highly resistant to 
H2O2, with an LD50 of approximately 200 μM. The difference in cell death seen for 
the Jurkat and B9 cells treated with 100 μM H2O2 was best illustrated by examining 
the contrast in PI staining, as determined by flow cytometry (Figure 3.8 inset). The 
data provided a statistically significant correlation (R2 = 0.7542, P<0.05) between 
Bcl-2 expression and resistance towards H2O2 (Figure 3.9). 
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Figure 3.8: Cell viability of Bcl-2 transfectants exposed to H2O2 after 24 hr. The 
Bcl-2 transfectants and control cells were challenged with a range of H2O2 doses and 
incubated for 24 hr. Cells were subsequently stained with PI and subjected to FACS 
analysis to differentiate the proportion of PI positive cells in the population. Values 
represent the mean + SE of 4 independent experiments. Inset is a FACS flow 
cytometry histogram of Jurkat (blue) and B9 (overlaid red) cells treated with 100 μM 
H2O2 24 hr after exposure. 
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Figure 3.9: Correlation between Bcl-2 expression and the LD50 of each clone to 
H2O2. The lethal dose required to kill 50% of the cells (LD50) in a population was 
determined from the cell death curves above. The LD50 values were plotted against 
the level of Bcl-2 expression for each clone and a significant correlation (R2=0.7542 
and p<0.05) was determined using SigmaStat (Jandel scientific).  
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3.3.6  Effect of Bcl-2 on the induction of apoptosis and necrosis 
 
Having shown that Bcl-2 protected Jurkat cells from H2O2-induced cell death, it was 
important to understand whether Bcl-2 was blocking apoptosis, necrosis, or both. The 
B9 clones exhibited distinct differences in cell morphology when treated with H2O2 
(Figure 3.10). H2O2-treated B9 clones showed no signs of apoptotic cell death at any 
dose, but did become necrotic at higher doses.  
 
 
B9 control 
 
B9 50 μM 
 
B9 100 μM 
 
B9 200 μM
 
Figure 3.10: Morphology of B9 clones exposed to H2O2. Cells were treated with 
H2O2 for 6 hr. Images are representative of 3 independent experiments.  
 
 
These phenotypic observations of cell death were verified by carrying out caspase-3 
activity assays. As expected, the Neo-1 clone showed a biphasic response in caspase 
activity, similar to the parental Jurkat cell line, with caspase-3 activity present at the 
lower doses of H2O2 (Figure 3.11). However, there was no caspase 3 activation in the 
Bcl-2 transfectants, with the exception of the B2 clones, which peaked with a 3-fold 
increase in activity at 50 μM H2O2. To prove that Bcl-2 was not just delaying 
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apoptosis, caspase-3 assays were performed at later time-points (data not shown). 
These data failed to reveal any activation of caspase-3 in the Jurkat cells 
overexpressing Bcl-2. 
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Figure 3.11: Caspase-3 activity in H2O2 treated Bcl-2 transfectants. The Bcl-2 
transfectants were exposed to a range of H2O2 doses for 6 hr.  Cell samples were 
subsequently removed and assayed for caspase-3 activation by monitoring the 
cleavage of DEVD-AMC. Values represent the mean + SE of 3 independent 
experiments. 
 
 
 
The results achieved so far suggest that Bcl-2 protects cells from apoptosis in 
response to H2O2. Correlations were undertaken between Bcl-2 expression and cell 
survival, after treatment with apoptotic and necrotic doses of H2O2 (Figure 3.12). As 
predicted, there was a significant (p<0.05) positive correlation between Bcl-2 
expression and cell survival after exposure to an apoptotic dose of H2O2. However, no 
such correlation could be found between Bcl-2 expression and cell survival after 
being challenged with a necrotic dose of H2O2. 
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Figure 3.12: Correlation between Bcl-2 expression and cell survival after treatment 
with apoptotic (A) and necrotic (B) doses of H2O2. A significant correlation was 
found between Bcl-2 expression and cell survival after exposure to apoptotic doses of 
H2O2 (p<0.05), but not necrotic doses of H2O2. Values for the percentage of viable 
cells after treatment were plotted against the level of Bcl-2 expression for each clone 
and a significant correlation (R2=0.7542 and p<0.05) was determined using 
SigmaStat (Jandel scientific). 
 
 
 
3.3.7  Effect of caspase inhibition on cell viability of H2O2 treated Jurkats 
 
The pan-caspase inhibitor z-VAD.fmk was incubated with cells prior to H2O2 
exposure, in order to differentiate between the resistance provided by caspase 
inhibition, compared with the protection provided by Bcl-2 overexpression. Jurkat 
cells incubated with z-VAD.fmk did not undergo the characteristic membrane 
blebbing in response to H2O2. Furthermore, caspase activation was blocked in H2O2 
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treated Jurkats pre-treated with z-VAD.fmk (Figure 3.13A). Caspase inhibition 
decreased the cell death seen in H2O2-treated Jurkat cells to approximately half that of 
the control (Figure 3.13B). Interestingly, Bcl-2 overexpression provided a far greater 
level of protection from H2O2-induced cell death than caspase inhibition. 
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Figure 3.13: Response of Jurkat cells treated with H2O2 in the presence of z-
VAD.fmk (1 mM). (A) Cell samples were removed 6 hr after exposure and assayed 
for caspase-3 activity by monitoring the cleavage of DEVD-AMC. (B) Cells were 
stained with PI 24 hr after exposure and subjected to FACS analysis to determine the 
%PI positive (dead) cells. Values represent the mean + SE of 3 individual 
experiments. * Indicates a significant difference (p<0.05) between variables as 
determined by a One Way Repeated Measures ANOVA with Bonferroni multiple 
comparison (SigmaStat). 
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3.4   Discussion 
 
An initial characterisation of the Jurkat cells and Bcl-2 transfectants revealed that Bcl-
2 overexpression prevented Fas-mediated apoptosis. Such findings are in agreement 
with previous studies performed by Kawawhara et al. on Fas-treated Jurkat cells 
(Kawahara et al. 1998). Treatment of Jurkat cells with H2O2 caused a dose-dependent 
increase in cell death. The LD50 ascertained for Jurkat cells treated with H2O2 (50 
μM) corroborated the findings of former studies (Carayon et al. 1996; Barbouti et al. 
2002), and also consistent with previous reports, the cells showed apoptotic 
morphology at intermediate doses (25-150 μM H2O2) and necrotic morphology at 
higher doses (> 150 μM H2O2)  (Hampton and Orrenius 1997, 1998; Troyano et al. 
2003). This data demonstrated that there was a narrow dose window in which H2O2 
caused the activation of caspase-3. Hampton et al. have previously investigated the 
response of Jurkat cells challenged with H2O2 (Hampton and Orrenius 1997). In 
support of our current study, the authors reported a long lag phase before caspase-3 
activation (around 4 - 6 hr) and a similar biphasic response in caspase-3 activity. 
 
Bcl-2 protected Jurkat cells from H2O2-induced cell death in an expression-dependent 
manner. The overexpression of Bcl-2 blocked apoptotic features including membrane 
blebbing and caspase-3 activation. Interestingly, Bcl-2 overexpression only prevented 
cell death at the doses of H2O2 that caused caspase-3 activation (0-125 μM H2O2). 
Hence, Bcl-2 may only be protecting cells from H2O2 by blocking the apoptotic 
response. In support of these findings, a significant positive correlation was found 
between Bcl-2 expression and cell survival after exposure to apoptotic doses of H2O2. 
However, no such correlation could be established at necrotic doses of H2O2. 
Together, these data are consistent with a model in which Bcl-2 protects cells from 
H2O2 by blocking H2O2-induced apoptosis but not necrosis (Figure 3.14). 
 
These findings are consistent with previous studies demonstrating that Bcl-2 blocks 
oxidant-induced apoptosis, but not necrosis (Torigoe et al. 1994; Ichimiya et al. 1997; 
Bojes et al. 1998; Ichimiya et al. 1998; Rimpler et al. 1999; Amstad et al. 2001; Jang 
and Surh 2004). For example, Chen et al. transfected bakers yeast (Saccharomyces 
cerevisiae) with human Bcl-2 and found that the transfectants were protected from 
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oxidative stress-induced apoptosis (Chen et al. 2003). In the same study, they reported 
that both Bcl-2 transfected and wild type strains were equally susceptible to 
verapamil, an inducer of necrosis. However, there are contradictory reports suggesting 
that Bcl-2 may block necrotic cell death in some circumstances (Kane et al. 1995; 
Tsujimoto et al. 1997; Troyano et al. 2003). In each case, the death-inducing stimuli 
are ROS. These findings are consistent with the hypothesis that Bcl-2 may protect 
cells from oxidants by a mechanism distinct from preventing apoptosis 
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Figure 3.14: Summary model of Jurkat (A) and B9 (B) cells response to H2O2. Cell 
death (closed circles) and caspase-3 activity (open circles) are modulated depending 
on the dose. Bcl-2 blocks H2O2-induced apoptosis but not necrosis. 
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Recent studies have observed that ROS can modulate the expression of Bcl-2 with 
antioxidants enhancing Bcl-2 expression and ROS downregulating expression 
(Hildeman et al. 2003; Hildeman 2004). This phenomenon has been observed in 
Jurkat cells, which downregulate Bcl-2 expression when exposed to 100 μM H2O2 
(Chiaramonte et al. 2001). Furthermore, ROS can modulate Bcl-2 at the post-
translational level by promoting the ubiquitination and subsequent inactivation of Bcl-
2 (Li et al. 2004).  The modulation of Bcl-2 expression and activity may play a role in 
the current study, by shifting the apoptosis-survival equilibrium in favour of 
apoptosis.  
 
Pre-treatment of Jurkat cells with the pan-caspase inhibitor z-VAD.fmk prevented 
half of the cell death seen in response to 100 μM H2O2. The inability of z-VAD.fmk 
to completely inhibit cell death induced by ROS has been observed in previous 
studies (Kim et al. 2000; Uedaa et al. 2001; Scoltock and Cidlowski 2004; Scheller et 
al. 2006). In many cases, z-VAD.fmk simply changes the mode of cell death from 
apoptosis to necrosis. In contrast, the overexpression of Bcl-2 provided almost 
complete protection for Jurkat cells exposed to 100 μM H2O2. Such findings suggest 
that Bcl-2 protects cells from H2O2 by a mechanism that is distinct from its ability to 
prevent caspase activation (Figure 3.15).  
 
 
 
Figure 3.15: Summary diagram showing the pathways of H2O2-induced cell death. 
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Caspase inhibition may not protect cells as well as Bcl-2 overexpression if some form 
of caspase-independent apoptosis occurs. Alternatively, Bcl-2 may offer additional 
protection by enhancing the antioxidant status of the cell, and from offering some 
protection against necrosis that might occur at lower doses of H2O2. 
 
In summary, the results in this chapter have shown that Bcl-2 protects cells from 
H2O2-induced apoptosis. The protection provided by Bcl-2 could not be explained by 
caspase inhibition alone. Hence, it was important to investigate the possible 
antioxidant properties of Bcl-2 function. The effect of Bcl-2 on the antioxidant 
capacity of Jurkat cells is the focus of the next chapter. 
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Chapter 4: Effect of Bcl-2 expression on  
the antioxidant capacity of Jurkat T cells 
            
 
 
4.1 Introduction 
 
Despite a wealth of data, the exact mechanism by which Bcl-2 functions remains 
controversial. As discussed in chapter 1 (section 1.2.3), several lines of evidence have 
revealed that Bcl-2 overexpression enhances the antioxidant capacity of the cell 
(Voehringer 1999; Jang and Surh 2003; Kowaltowski and Fiskum 2005) and it is 
believed by some researchers that the antioxidant properties of Bcl-2 protect cells from 
apoptosis. Previous studies have reported a link between Bcl-2 expression and the level 
of endogenous glutathione (Ellerby et al. 1996; Mirkovic et al. 1997; Meredith et al. 
1998; Papadopoulos et al. 1998; Tyurin et al. 1998; Ellerby and Bredesen 2000; Lee et al. 
2001; Hoetelmans et al. 2003; Jang and Surh 2003, 2004a). The Bcl-2-dependent rise in 
glutathione causes a concomitant increase in the concentration of protein thiols (Ellerby 
et al. 1996; Tyurin et al. 1998). It is well established that glutathione can block the 
induction of apoptosis by scavenging reactive oxygen species (ROS) (Sies 1999). 
Interestingly, there are several reports showing that Bcl-2 overexpressing cells can be 
resensitised to apoptosis by glutathione depletion (Mirkovic et al. 1997; Armstrong and 
Jones 2002). In addition to glutathione, the overexpression of Bcl-2 has been shown to 
increase the activity of the major antioxidant enzymes superoxide dismutase (Steinman 
1995; Ellerby et al. 1996; Bruce-Keller et al. 1998; Papadopoulos et al. 1998; Lee et al. 
2001), catalase (Steinman 1995; Bruce-Keller et al. 1998; Del Bufalo et al. 2001; Lee et 
al. 2001; Jang and Surh 2004b), and glutathione peroxidase (Bruce-Keller et al. 1998; 
Papadopoulos et al. 1998). The overexpression of these antioxidant enzymes has been 
shown to protect cells from apoptosis (Sandstrom and Buttke 1994; Rabizadeh et al. 
1995; Gouaze et al. 2002). Other antioxidants, such as the peroxiredoxins, can also block 
apoptosis by preventing the accumulation of ROS (Zhang et al. 1997; Chang et al. 2004). 
As yet, no antioxidant enzyme has consistently been shown to be upregulated in cells 
overexpressing Bcl-2, suggesting that the impact of Bcl-2 on the activity of antioxidant 
enzymes is cell line-dependent. Indeed, several studies have reported that Bcl-2 has no 
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effect on the activity of antioxidant enzymes (Lee and Shacter 1997; Schor et al. 2000; 
Amstad et al. 2001).  
 
In the previous chapter, it was demonstrated that Bcl-2 could protect cells from apoptosis 
at intermediate doses of H2O2. This could be due to its broad-spectrum inhibition of 
apoptosis, or the ability to protect the cells against oxidative stress. The purpose of the 
current chapter was to test the second possibility by performing a systematic study of the 
effect of Bcl-2 overexpression on the antioxidant status of Jurkat cells.  
 
The main objectives of this chapter were: 
 
1) To determine whether the levels and activity of antioxidant enzymes were altered 
in Jurkat cells overexpressing Bcl-2. 
 
2) To examine the link between Bcl-2 expression and cellular thiol homeostasis in 
Jurkat cells overexpressing Bcl-2. 
 
 
4.2 Experimental approach 
 
Jurkat cells and Bcl-2 transfectants, as described in chapter 3 (section 3.2), were cultured 
and cell lysates prepared. The lysates were tested for antioxidant enzyme expression and 
activity. Superoxide dismutase activity was measured by employing a superoxide (O2-.) 
generating system (xanthine/xanthine oxidase) to reduce a water-soluble tetrazolium dye 
(WST-1) in the presence of a range of concentrations of superoxide dismutase (Peskin 
and Winterborn 2000). The presence of superoxide dismutase in the reaction mixture 
removes O2-. and thereby prevents the reduction of WST-1. Catalase activity was 
determined by measuring the decomposition of H2O2 over time on the spectrophotometer 
(Aebi 1984). A coupled spectrophotometer assay involving glutathione reductase was 
utilised to monitor glutathione peroxidase activity (Flohe and Gunzler 1984). 
Thioredoxin reductase activity was determined by measuring the NADPH-dependent 
reduction of the thiol-reactive probe 5,5’-dithiobis (2-nitrobenoic acid) (DTNB) (Arner et 
al. 1999). The expression level of the antioxidant proteins glutathione peroxidase (1, 3 
and 4), thioredoxin reductase (1 and 2), thioredoxin 1 and the peroxiredoxins (1,2,3,4,5 
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and 6) were determined by immunoblotting. Intracellular thiols were measured using 
DTNB (Ellman 1958). 5-Iodoacetamidofluorescein (5-IAF) was utilised to specifically 
label protein thiols, which were subsequently visualised by electrophoresis (Baty et al. 
2002). H2O2 consumption was measured by using the ferrous oxidation of xylenol orange 
(FOX) assay (Wolff 1994). 
 
 
4.3 Results 
4.3.1  Assessing superoxide dismutase activity in Jurkat cells and Bcl-2 transfectants 
 
Superoxide dismutase (SOD) is an antioxidant enzyme that converts O2-. to H2O2 
(Fridovich 1995). Two isoforms of SOD, CuZn-SOD and Mn-SOD, are present in cells. 
While CuZn-SOD is localised to the cytoplasm, Mn-SOD is present in the mitochondria 
(MacMillan-Crow and Cruthirds 2001; McCord 2002). The total SOD activity of each 
lysate was examined by monitoring the inhibition of WST-1 reduction in the presence of 
a range of cell lysate concentrations (Figure 4.1). SOD activity was calculated by 
determining the IC50 for each lysate, which, by definition, is equal to one unit of SOD 
activity (Peskin and Winterborn 2000).  
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Figure 4.1: Determination of SOD activity. SOD activity (U/mg) was calculated by 
estimating the amount of lysate required to inhibit WST-1 reduction by 50% (IC50). 
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The cell lysates displayed a similar level of SOD activity, ranging from 350-424 U/mg 
(Figure 4.2A). There was no significant correlation between Bcl-2 and total SOD activity 
(P>0.05) (Figure 4.2B). The SOD assay was also performed in the presence of 5 mM 
KCN, which inhibits CuZn-SOD, leaving only active Mn-SOD (Paci et al. 1988). The 
“CN-insensitive” SOD (Mn-SOD) activity was very similar in each of the Bcl-2 
transfectants, ranging from 100-130 U/mg (Figure 4.2A). Again, there was no significant 
correlation between Bcl-2 expression and the activity of “CN-insensitive” SOD (Figure 
4.2B). 
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Figure 4.2: SOD activity in cell lysates of Bcl-2 transfectants. Values represent the 
mean + SE of 3 independent experiments. “CN-insensitive” SOD activity was monitored 
in the presence of 5 mM KCN. Correlation between Bcl-2 expression and SOD activity 
generated using Sigma stat (not significant P>0.05). 
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4.3.2  Assessing catalase activity in Jurkat cells and Bcl-2 transfectants 
 
Catalase is an antioxidant enzyme that decomposes H2O2 to form oxygen and water (Aebi 
1984; Brioukhanov and Netrusov 2004). In order to evaluate whether Bcl-2 expression 
affects catalase function, cell lysates of the Bcl-2 transfectants were assayed for catalase 
activity. Catalase activity showed little variability between the clones, ranging from 7.1-
9.2 U/mg (Figure 4.3A). Moreover, there was no correlation between the activity of 
catalase and the level of Bcl-2 expression (P>0.05) (Figure 4.3B).  
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Figure 4.3: Catalase activity in cell lysates of Bcl-2 transfectants. Catalase activity was 
measured in cell lysates by following the decomposition of H2O2 on a spectrophotometer 
at 240nm. Values represent the mean + SE of 3 independent experiments. B) Correlation 
between Bcl-2 expression and catalase activity generated using Sigma stat (not 
significant P>0.05). 
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4.3.3  Assessing glutathione peroxidase in Jurkat cells and Bcl-2 transfectants 
 
The glutathione peroxidases are ubiquitous antioxidant enzymes that use glutathione to 
decompose H2O2 (Lei 2002). There are five isoforms that reside in different sub-cellular 
locations, one of which (glutathione peroxidase 4) specifically reduces organic 
hydroperoxides (Imai and Nakagawa 2003). To clarify the influence of Bcl-2 expression 
on glutathione peroxidase, both the level of expression and activity of the enzyme were 
determined. The expression of glutathione peroxidase 1, 3, and 4 was monitored via a 
densitometry analysis of the immunoblot band of interest, which travelled at 
approximately 26 kDa (Figure 4.4). The densitometry analysis revealed that there was no 
significant correlation (P>0.05) between Bcl-2 expression and the expression of any of 
the glutathione peroxidase isoforms (Figure 4.5). The glutathione peroxidase activity 
showed some variation among the Bcl-2 transfectants ranging from 0.093-0.13 U/mg 
(Figure 4.6A); however, a lack of correlation between Bcl-2 expression and glutathione 
peroxidase activity demonstrated that there was no statistically significant trend between 
the variables (P>0.05) (Figure 4.6B).  
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Figure 4.4: Immunoblot detection of the glutathione peroxidases (isoforms 1, 3 and 4).  
(A) Cell lysates were resolved by SDS-PAGE and immunoblotted using polyclonal 
antibodies against Glutathione peroxidase (Gpx) 1, 3 and 4 respectively. (B) 
Densitometry histogram of immunoblots in the Bcl-2 transfectants. The bands were 
quantified using Quantity-One (BioRad). Values represent the mean + SE of 3 
independent experiments. 
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Figure 4.5: Correlations between Bcl-2 expression and glutathione peroxidase 
expression. Correlations were generated using Sigma stat (not significant P>0.05). 
Values were determined by immunoblot detection (Figure 4.4) and represent the mean of 
at least 3 independent experiments.    
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Figure 4.6: Glutathione peroxidase activity in cell lysates of Bcl-2 transfectants. (A) 
Cell lysates were assayed for glutathione peroxidase activity in a spectrophotometer 
assay developed by Flohe et el (Flohe and Gunzler 1984). Values represent the mean + 
SE of 3 independent experiments. (B) Correlation between Bcl-2 expression and 
glutathione peroxidase activity generated using Sigma stat  (not significant P>0.05). 
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4.3.4  Assessing the levels of the peroxiredoxin isoforms in Bcl-2 transfectants 
 
The peroxiredoxins are a novel family of peroxidases that use a redox-active cysteine to 
decompose H2O2 (Rhee et al. 2005b). The six mammalian peroxiredoxin isoforms reside 
in different cellular compartments and use different mechanisms to reduce H2O2 (Wood 
et al. 2003). The expression levels of the peroxiredoxins (isoforms 1-6) were tested in the 
Bcl-2 transfectants using isoform-specific antibodies (Figure 4.7). A densitometry 
analysis of the Western blots revealed that there were no significant differences in the 
expression of any peroxiredoxin in any of the Bcl-2 transfectants (Figure 4.8). 
Furthermore, correlations between Bcl-2 expression and peroxiredoxin expression were 
not significant (P>0.05).  
 
 
 
 
 
Figure 4.7: Immunoblot detection of the peroxiredoxins (isoforms 1-6). Cell lysates 
were resolved by SDS-PAGE and immunoblotted using polyclonal antibodies against 
peroxiredoxin 1-6 (Prx 1-6) respectively. Western blots are representative of at least 3 
independent experiments. 
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Figure 4.8: Peroxiredoxin expression in Bcl-2 transfectants. Densitometry analysis of 
peroxiredoxins 1-2 (A), 3-4 (B) and 5-6 (C) for each cell line. The bands were quantified 
using Quantity-One (BioRad). Values represent the mean + SE of 3 independent 
experiments. Correlations between Bcl-2 expression and peroxiredoxin expression were 
determined using Sigma stat. Closed circles represent peroxiredoxin 1 (A), 3(B) and 5 
(C) while open circles represent peroxiredoxin 2 (A), 4 (B) and 6(C). No correlations 
reached significance (not significant P>0.05).  
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4.3.5  Assessing the thioredoxin/thioredoxin reductase system in Bcl-2 transfectants 
 
Given that Bcl-2 has been reported to augment the redox potential of a cell, the 
thioredoxin/thioredoxin reductase system in the Bcl-2 transfectants was assessed. The 
thioredoxin/thioredoxin reductase system is involved in reducing oxidised protein thiols 
and disulfides at the expense of NADPH (Mustacich and Powis 2000). The levels of 
thioredoxin 1, thioredoxin reductase 1, and thioredoxin reductase 2 were detected by 
immunoblotting and densitometry (Figure 4.9). The densitometry revealed no significant 
changes in the levels of thioredoxin 1, thioredoxin reductase 1 or 2 in the Bcl-2 
transfectants. Furthermore, there was no significant correlation between Bcl-2 expression 
and the level of thioredoxin or thioredoxin reductase 1 and 2 (P>0.05) (Figure 4.10). 
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Figure 4.9: Immunoblot detection of proteins involved in the thioredoxin reducing 
system.  Cell lysates were resolved by SDS-PAGE and immunoblotted using polyclonal 
antibodies against thioredoxin 1 (Trx1) thioredoxin reductase 1 (TrxRed1) and 
thioredoxin reductase 2 (TrxRed 2) respectively (previous page, A). B) Densitometry 
analysis of immunoblots. Bands were quantified using Quantity-One (BioRad). Values 
represent the mean + SE of 3 independent experiments. 
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Figure 4.10: Correlation between Bcl-2 and thioredoxin or thioredoxin reductase 
expression. Correlations between Bcl-2 expression and Trx 1 (A), TrxRed 1 (B), or 
TrxRed 2 (C) expression were generated using Sigma stat  (not significant P>0.05). 
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In addition to immunoblotting, the activity of thioredoxin reductase was ascertained for 
each Bcl-2 transfectant. The activity of thioredoxin reductase did not vary much between 
the transfectants ranging from 0.072-0.095 ΔA412 nm/min (Figure 4.11A). Moreover, no 
significant correlation was found between Bcl-2 expression and thioredoxin reductase 
activity (P>0.05) (Figure 4.11B).  
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Figure 4.11: Activity of thioredoxin reductase in cell lysates of Bcl-2 transfectants. (A) 
Cell lysates were assayed for thioredoxin reductase activity by measuring the NADPH-
dependent reduction of DTNB. Values represent the mean + SE of 3 independent 
experiments. (B) Correlation between Bcl-2 expression and thioredoxin reductase activity 
generated using Sigma stat (not significant P>0.05). 
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4.3.6  Determining the level of endogenous thiols present in Bcl-2 transfectants 
 
Endogenous thiols can act as cellular antioxidants by scavenging ROS. The total 
concentration of endogenous thiols, which includes both low molecular weight thiols and 
protein thiols, was examined in cell lysates of the Jurkat cells and Bcl-2 transfectants. 
The level of endogenous thiols was relatively similar among the cells tested, ranging 
from 50-70 nM/mg (Figure 4.12A). To determine whether or not there was any tendency 
for Bcl-2 overexpressing cells to have more intracellular thiols, a correlation between 
Bcl-2 expression and intracellular thiol concentration was performed (Figure 4.12B). The 
data confirmed that there was no statistically significant correlation between Bcl-2 
expression and intracellular thiol concentration (p>0.05). 
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Figure 4.12: Detection of reduced thiols in cell extracts using the DTNB assay. (A) Cell 
extracts were aliquoted into a microplate and reacted with DTNB to produce a yellow 
product (TNB) that could be detected by spectrophotometry at 412 nm. Sample readings 
were compared to a standard curve of glutathione to generate thiol concentrations 
(nM/mg) for each cell lysates. Values represent the mean + SE of 3 independent 
experiments. (B) Correlation between Bcl-2 expression and intracellular thiols generated 
using Sigma stat (not significant P>0.05). 
Chapter 4    
   
Protein thiols were isolated from cell lysates by TCA precipitation. The isolation of 
protein thiols ensured that low molecular weight redox buffering molecules, such as 
glutathione, would be excluded. The protein thiol concentrations in the Bcl-2 
transfectants ranged from 25-32 nM/mg (Figure 4.13A). Interestingly, there was a 
negative correlation between Bcl-2 expression and protein thiol concentration that just 
reached significance (P<0.05) (Figure 4.13B).  
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Figure 4.13: Detection of reduced protein thiols in cell extracts using the DTNB assay. 
(A) Protein was extracted from cell extracts by TCA precipitation. Extracted protein was 
resolubilised, reacted with DTNB and detected by spectrophotometry at 412 nm. Thiol 
concentrations (nM/mg) were generated using a standard curve of glutathione. Values 
represent the mean + SE of 3 independent experiments. (B) Significant negative 
correlation between Bcl-2 expression and protein thiols generated using Sigma stat (P< 
0.05, r2 = -0.715).  
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In order to further investigate changes in protein thiols between the Bcl-2 transfectants, 
an alternative method of protein thiol labelling was utilised. Protein thiols from cell 
lysates were labelled using the thiol-reactive fluorescent probe 5-IAF. 5-IAF labelled cell 
lysates from Bcl-2 transfectants were analysed by SDS-PAGE and imaged using a 
BioRad FX fluorescence scanner. Despite slight variations in band intensity, due to 
protein loading, there were no major differences in the banding pattern of each cell line 
(Figure 4.14).  
 
 
 
   
           Jurkat     N1     N2      B1     B2      B9    B36   B38 
 
Figure 4.14: Illustrative gel of IAF-labelled reduced thiols in cell extracts. The gel is 
illustrative of 3 independent experiments. Cell extracts from the Bcl-2 transfectants were 
incubated with 200 μM 5-IAF and resolved by SDS-PAGE. Gels were imaged with a 
BioRad FX fluorescence scanner using Ex λ=488 nm and Em λ=530 nm (Bio-Rad 
Laboratories, Hercules, CA, USA). 
 
 
 
 
4.3.7  Assessing the rate of H2O2 consumption in Jurkat and B9 cells 
 
H2O2 consumption was measured in Jurkat and B9 cells overexpressing Bcl-2 following 
treatment with a 50 μM or 200 μM bolus of H2O2. The FOX assay data revealed that the 
Jurkat and B9 cells consumed the 50 μM bolus of H2O2 at a comparable rate (Figure 
4.15A). The B9 cells consumed more H2O2 during the initial 2 minutes of exposure; 
however, this was not statistically significant. A similar trend for H2O2 consumption was 
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seen in Jurkat and B9 cells treated with 200 μM H2O2 (Figure 4.15B). Interestingly, the 
majority of the 200 μM H2O2 dose was consumed within the 30-minute time course in 
both cell lines. 
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Figure 4.15: Assessing H2O2 consumption in Jurkat and B9 cells treated with a bolus 
of H2O2. Jurkat and B9 cells were cultured in fresh RPMI at a concentration of 1x106 
cells/ml prior to the addition of either a 50 μM (A) or a 200 μM (B) bolus of H2O2. 
Aliquots of H2O2 treated cell culture or media alone were removed at various time-points 
and added to FOX reagent. Samples were left to incubate for 40 minutes before being 
read on a spectrophotometer at 560 nm and related back to a H2O2 standard curve. 
Values represent the mean + SE of 3 independent experiments. 
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4.4 Discussion 
 
The aim of this chapter was to examine potential antioxidant properties of Bcl-2. No 
changes were observed in any antioxidant enzymes that could explain the resistance of 
Jurkat cells overexpressing Bcl-2 to H2O2-induced apoptosis. The overexpression of Bcl-
2 had no affect on the activity of CuZn-SOD, Mn-SOD, catalase, or Gpx. Previous 
studies have failed to reach a consensus as to whether or not the overexpression of Bcl-2 
enhances the activity of these antioxidant enzymes (Table 4.1) (Steinman 1995; Ellerby 
et al. 1996; Bruce-Keller et al. 1998; Papadopoulos et al. 1998; Amstad et al. 2001; Del 
Bufalo et al. 2001; Lee et al. 2001; Jang and Surh 2004b). Investigators that have 
examined Mn-SOD activity in cells overexpressing Bcl-2 found no change when 
compared to untransfected controls (Bruce-Keller et al. 1998; Lee et al. 2001; Jang and 
Surh 2004b). Interestingly, overexpression of the Bcl-2 homologue, Bcl-xL, does not alter 
the activity of any of these antioxidant enzymes (Bojes et al. 1997). Furthermore, Bcl-2 
deficient mice display a marked variability in Gpx activity that is age-dependent 
(Hochman et al. 2000). These studies underscore the complex nature of any relationship 
between Bcl-2 expression and antioxidant enzyme activity. 
 
 
 
Table 4.1: Summary table displaying the effect of Bcl-2 expression on antioxidant 
enzyme activities in transfected cells. 
 
Chapter 4    
   
The disparity between our study and others showing that Bcl-2 has antioxidant properties 
may reflect differences in the cell lines used (Hockenbery et al. 1993; Ellerby et al. 1996; 
Schor and Kagan 1997; Lee et al. 2001; Kowaltowski et al. 2004). Indeed, investigators 
who have used human lymphoma cell lines have come to a similar conclusion that there 
are no antioxidant aspects to Bcl-2 function (Lee and Shacter 1997). The cell line-
dependence of the “Bcl-2 antioxidant phenomenon” has been emphasised by several 
studies demonstrating that Bcl-2 overexpression can alter antioxidant enzyme activity and 
thiol antioxidant capacity in some transfected cell types but not others (Ellerby et al. 
1996; Schor et al. 2000; Lee et al. 2001).  
 
Many of the studies reporting that Bcl-2 has antioxidant properties have been performed 
using only a single Bcl-2 clone (Hockenbery et al. 1993; Mirkovic et al. 1997; Tyurina et 
al. 1997; Papadopoulos et al. 1998; Rimpler et al. 1999; Amstad et al. 2001; Jang and 
Surh 2004a). Results attained by comparing a single Bcl-2 clone to the parental cell line 
need to be interpreted with caution, for several reasons. Firstly, the minor fluctuations 
seen between the cell lines in the current study highlight the importance of using multiple 
clones, so that differences observed can be correlated to the level of Bcl-2 expression. 
Otherwise, minor alterations may mistakenly be interpreted as Bcl-2 dependent changes 
in the antioxidant capacity of cells. Secondly, the selection procedure used to isolate Bcl-
2 clones, which involves exposing cells to high levels of geneticin, may promote the 
survival of clones with elevated antioxidant status, independent of the transgene 
involved.  
 
To the best of my knowledge, this was the first time that the expression or activity of Prx 
and Trx Red was examined in cells overexpressing Bcl-2. Consistent with our earlier 
observations in this chapter, Bcl-2 overexpression did not modulate the expression or 
activity of these antioxidant enzymes. The lack of any changes in Prx expression is of 
special interest given the ability of Prx to participate in apoptotic redox signalling (Rhee 
et al. 2005a). For instance, overexpression of the cytosolic (Prx-2) or mitochondrial (Prx-
3) isoforms of Prx can prevent apoptosis (Zhang et al. 1997; Chang et al. 2004), while 
reducing the expression of endogenous Prx 3, by RNA interference (siRNA), sensitises 
cells to apoptotic stimuli (Chang et al. 2004). 
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The current study has shown that Bcl-2 expression has no discernable effect on either the 
intracellular thiol concentration or the level of protein thiols. These data suggest that Bcl-
2 does not enhance the thiol antioxidant capacity of Jurkat cells. The protein thiol 
concentrations found in this study (~ 30 nM/mg protein) are in accordance with values 
determined in previous investigations (Morina et al. 2001; Beer et al. 2004). The data 
conflict with earlier reports that have found a noticeable increase in the level of protein 
thiols in cells overexpressing Bcl-2 (Ellerby et al. 1996; Tyurin et al. 1998). However, as 
described previously, such contrasting results may reflect the cell-line dependence of 
thiol homeostasis (Schor et al. 2000). 
 
The rate of H2O2 clearance was very similar in both the Jurkat and B9 cells, suggesting 
that Bcl-2 overexpression did not affect H2O2 catabolism. Previous studies examining 
H2O2 consumption in Jurkat cells found strikingly similar rates of degradation, 
confirming that the methodology used to monitor H2O2 was sound (Hampton and 
Orrenius 1997). Our findings are in agreement with those of several groups (Lee and 
Shacter 1997; Zhao et al. 2000), one of which demonstrated that Bcl-2 expression did not 
correlate with H2O2 decomposition. Together, these results bring into question the 
hypothesis that Bcl-2 enhances the activity of H2O2-decomposing enzymes.  
 
In summary, the results in this chapter have clearly shown that Bcl-2 does not enhance 
the antioxidant capacity of Jurkat cells. Furthermore, there was no correlation between 
Bcl-2 expression and the expression or activity of any of the antioxidant enzymes studied. 
Together, these findings suggest that Jurkat cells overexpressing Bcl-2 are no better at 
detoxifying oxidative insults than control cells. Therefore, such cells may well exhibit a 
similar level of oxidative damage as the parental Jurkat cells in response to treatment 
with H2O2. Assessing the effect of Bcl-2 on oxidative damage following exposure to 
H2O2 is the focus of the next chapter. 
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Chapter 5: Assessing oxidative damage following 
treatment with H2O2 in Bcl-2 transfectants 
            
 
 
5.1 Introduction 
 
H2O2 exposure can oxidatively damage cellular constituents such as lipids, protein 
and DNA (Finkel and Holbrook 2000). The oxidation of DNA by H2O2 is especially 
harmful because it promotes mutagenicity and genomic instability (Limoli and 
Giedzinski 2003; Valko et al. 2004; Zhivotovsky and Kroemer 2004). The 
overexpression of Bcl-2 has been shown to prevent many forms of oxidative damage 
(Kowaltowski and Fiskum 2005). Hockenbery and co-workers originally showed, in 
their groundbreaking study, that Bcl-2 overexpression could block H2O2-mediated 
lipid peroxidation (Hockenbery et al. 1993). Since this landmark paper, several other 
groups have demonstrated that the overexpression of Bcl-2 could prevent oxidant-
mediated lipid peroxidation (Fabisiak et al. 1997; Tyurina et al. 1997; Zhang et al. 
1997; Bruce-Keller et al. 1998). Bcl-2 has also been shown to lower protein carbonyl 
formation in response to oxidative stress (Lee et al. 2001). Furthermore, Bcl-2 
deficient mice show increased levels of protein carbonyls, supporting the proposal 
that Bcl-2 prevents protein oxidation (Hochman et al. 1998; Hochman et al. 2000). 
Other reports have revealed that the overexpression of Bcl-2 prevents the 
accumulation of both genomic and mitochondrial DNA damage (Deng et al. 1999; 
Godley et al. 2002; Mandavilli et al. 2005). However, the contradictory findings of 
various studies have made it difficult to accept that Bcl-2 universally prevents 
oxidative damage to all cell constituents (Zhong et al. 1993; Kuo et al. 1999; Seyfried 
et al. 2003). Indeed, in some circumstances, it seems that Bcl-2 overexpression can 
exacerbate oxidative damage to both lipids (Seyfried et al. 2003) and DNA (Kuo et al. 
1999) in response to oxidative insult.  
 
While it is possible that Bcl-2 itself directly protects against H2O2, it is also possible 
that Bcl-2 expression indirectly affects cellular oxidation. For example, there is 
increasing evidence that apoptosis leads to increased oxidant production (Zamzami et 
al. 1995; Um et al. 1996; Cai and Jones 1998), and by impairing apoptosis Bcl-2 
appears to be an antioxidant. Alternatively, if apoptotic stimuli, including H2O2, cause 
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oxidative damage, blocking apoptosis in these cells has the potential to result in the 
accumulation of cells with oxidative damage.  
 
The main objectives of this chapter were: 
 
1) To assess the level of lipid peroxidation occurring in Jurkat cells 
overexpressing Bcl-2. 
 
2) To determine the extent of protein carbonyls and thiol protein oxidation in 
Jurkat cells overexpressing Bcl-2. 
 
3) To assess genomic instability in Jurkat cells overexpressing Bcl-2. 
 
 
5.2 Experimental approach 
 
Jurkat cells and Bcl-2 transfected Jurkat clones (B9 cells) were cultured and 
challenged with H2O2 as described in previous chapters (Section 2.2, 2.3 and 3.2). 
Lipid peroxidation was assessed by using an oxidant-sensitive lipophilic dye that 
fluoresces green upon oxidation (Drummen et al. 2002). Previous work in our lab has 
demonstrated that glyceraldehyde phosphate dehydrogenase (GAPDH) and 
peroxiredoxin are susceptible to thiol oxidation (Baty et al. 2005). GAPDH thiol 
oxidation was monitored by using a fluorescent labelling method established in our 
laboratory (Section 2.18) (Baty et al. 2002). Peroxiredoxin overoxidation was 
monitored by immunoblotting with a polyclonal antibody specifically raised against 
the overoxidised form of the protein (Woo et al. 2003b). Protein carbonyls were 
measured using an enzyme-linked immunosorbent assay (ELISA) developed in our 
laboratory (Buss et al. 1997). Cell growth was monitored by counting viable cells 
under a light microscope on a daily basis. Genomic instability was measured by using 
the cytokinesis-block micronuclei (CBMN) assay (Fenech 2000, 2002). The principle 
of the assay is to block treated cells at telophase and scan the resulting binucleated 
cells for nuclear aberrations known as micronuclei (Hogstedt et al. 1981; Fenech 
2002). 
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5.3    Results 
5.3.1  Effect of H2O2 on lipid peroxidation in Jurkat and B9 cells 
 
Jurkat and B9 cells were loaded with C11-BODIPY581/591 for 30 min before exposure 
to 100 μM H2O2 for 1 hour and subsequent assessment of lipid peroxidation (green 
fluorescing C11-BODIPY581/591). Treated cells were visualised by fluorescence 
microscopy and analysed by flow cytometry. Challenging cells with H2O2 led to an 
increase in green fluorescence for both Jurkat and B9 cells (Figure 5.1). Furthermore, 
flow cytometry analysis revealed that H2O2 exposure caused a similar shift in green 
fluorescence for both cell lines (Figure 5.2A). Quantification of the flow cytometry 
data confirmed that the extent of lipid peroxidation was the same in Jurkat and B9 
cells (Figure 5.2B). 
 
     Jurkat Control         Jurkat Treated      B9 Control     B9 Treated 
 
Figure 5.1: Visualisation of lipid peroxidation in Jurkat and B9 cells following 
H2O2 exposure. Lipid peroxidation was observed by loading cells with the oxidant–
sensitive probe C11-BODIPY581/591 and assessing changes in fluorescence following 
exposure to 100 μM H2O2. C11-BODIPY581/591 fluoresces red in untreated cells (top 
row), but becomes oxidised fluorescing green (bottom row), following H2O2 exposure. 
Photomicroscopy images are representative of 3 independent experiments.  
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Figure 5.2: Quantifying lipid peroxidation in Jurkat and B9 cells treated with H2O2. 
Jurkat and B9 cells were loaded with C11-BODIPY581/591 and exposed to 100 μM 
H2O2 for 1 hr before being harvested and subjected to flow cytometry analysis for 
BODIPY-Green fluorescence (A). Values represent the mean + SE of at least 4 
independent experiments (B). * Indicates a significant difference (p<0.05) between 
variables as determined by a One Way Repeated Measures ANOVA with Bonferroni 
multiple comparison (SigmaStat). 
 
 
 
5.3.2  Measuring GAPDH thiol oxidation in response to H2O2 
 
The abundance of GAPDH and the reactivity of its cysteine residues make GAPDH 
thiol oxidation a good marker of protein oxidation (Little and Obrien 1969; Baty et al. 
2005). The dose-dependency of GAPDH thiol oxidation was examined in Jurkat and 
B9 cells treated with H2O2. Since the B9 cells were more resilient than Jurkat cells at 
higher doses of H2O2, one might imagine that the B9 cells would have shown fewer 
oxidised thiols. Interestingly, this was not the case; thiol oxidation at each H2O2 dose 
was indistinguishable (Figure 5.3A). Densitometry analysis of the GAPDH band 
intensity confirmed that there was a dose-dependent increase in thiol oxidation that 
was unaffected by Bcl-2 overexpression (Figure 5.3B).  
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Figure 5.3: GAPDH thiol oxidation in Jurkat and B9 cells exposed to various 
concentrations of H2O2. GAPDH thiol oxidation was monitored by 5-IAF-labelling in 
Jurkat and B9 cells exposed to various concentrations of H2O2 for 10 min. (A) 
Illustrative gel of 3 individual experiments displaying oxidised thiol-containing 
proteins in H2O2 treated cells. The oxidised thiols of harvested cell samples were 
fluorescently labeled, resolved by SDS-PAGE, and imaged using a fluorescent 
scanner. Gels were subsequently stained with Coommassie blue or silver stain to 
ensure equal protein loading. B) Densitometry of oxidised thiol-containing GAPDH 
band intensity.  Densitometry was performed using Quantity One (BioRad). Values 
represent the mean + SE of at least 3 independent experiments. 
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In addition, GAPDH oxidation was assessed in Jurkat and B9 cells treated with a 100 
μM bolus of H2O2 over a one-hour time period (Figure 5.4). The Jurkat and the B9 
cells displayed an approximately linear increase in GAPDH thiol oxidation over time. 
As predicted, GAPDH thiol oxidation was rapid and could be detected directly after 
the oxidative insult. Densitometry analysis of the oxidised thiol GAPDH band 
revealed that the rate of GAPDH thiol oxidation was comparable in both cell lines 
(Figure 5.5). 
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Figure 5.4: GAPDH thiol oxidation in Jurkat and B9 cells treated with H2O2 over 
time. GAPDH thiol oxidation was monitored over time in Jurkat and B9 cells treated 
with 100 μM H2O2 by 5-IAF-labelling. Illustrative gel of 3 independent experiments 
displaying oxidised thiol-containing proteins in H2O2 treated cells. The oxidised thiols 
of harvested cell samples were fluorescently labeled, resolved by SDS-PAGE, and 
imaged using a fluorescent scanner. Gels were subsequently stained with 
Coommassie blue or silver stain to ensure equal protein loading. 
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Figure 5.5: Densitometry analysis of GAPDH thiol oxidation in Jurkat and B9 cells 
treated with H2O2 over time. Jurkat and B9 cells were treated with 100 μM H2O2 and 
oxidised thiols were labeled with 5-IAF. Densitometry was performed using Quantity 
One (BioRad). Values represent the mean + SE of at least 3 independent experiments 
 
 
 
5.3.3  Monitoring peroxiredoxin overoxidation in response to H2O2 
 
The cysteine residue in the active site of the peroxiredoxins can readily become 
overoxidised in response to H2O2 exposure (Rabilloud et al. 2002; Georgiou and 
Masip 2003), leading to the formation of the sulfinic acid (Cys-SO2H), which can be 
detected immunologically (Woo et al. 2003b). Jurkat and B9 cells were treated with 
100 μM H2O2 and samples were collected periodically over time in a lysis buffer 
containing 10 mM NEM. The presence of NEM in the lysis buffer freezes the redox-
state of the cell and ensures that no thiol oxidation or reduction takes place (Gitler et 
al. 1994). Sample lysates were analysed by SDS-PAGE in non-reducing conditions 
and immunoblotted against the overoxidised (Cys-SO2H) form of the peroxiredoxins. 
The immunoblots revealed that the overoxidised form of the peroxiredoxins formed 
immediately after H2O2 exposure in both cell lines (Figure 5.6A). Interestingly, the 
amount of overoxidation did not decrease during the first hour of treatment. These 
data suggest that the overoxidised form of the peroxiredoxins remains, even when the 
level of oxidant has dissipated (section 4.3).  
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Figure 5.6: Detection of overoxidised peroxiredoxins in Jurkats and B9s treated 
with H2O2. Illustrative Western blots of 3 independent experiments against Prx-SO3 
(A) and Prx2 (B) in H2O2 challenged Jurkats and B9s.  Jurkat and B9 cells treated 
with 100 μM H2O2 were harvested periodically over time. Harvested cells were lysed, 
and mixed with non-reducing sample buffer. Samples were analysed by SDS-PAGE, 
blotted onto PVDF membrane and immunoblotted for the relevant antibody.   
 
 
 
Stripping and reprobing the membrane for peroxiredoxin 2 confirmed that the 
differences seen between controls and treated cell lysates were not an artifact of 
protein loading (Figure 5.6B). Peroxiredoxin 2 forms a disulfide-linked dimer in 
healthy cells during its catalytic cycle (Rhee et al. 2005). Interestingly, when control 
lysates were resolved in non-reducing conditions in the absence of NEM, only the 
dimer was present, suggesting that peroxiredoxin 2 spontaneously dimerises upon 
lysis. This phenomenon has been observed previously in the laboratory (Felicia Low, 
personal communication). When peroxiredoxin 2 is overoxidised it is unable to form 
dimers. The fact that there was no dimer present in the treated cells suggests that the 
entire pool of peroxiredoxin 2 becomes overoxidised in Jurkat and B9 cells treated 
with 100 μM H2O2. 
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5.3.4  Effect of H2O2 on protein carbonyl formation in Jurkat and B9 cells 
 
Another approach used to assess oxidative stress in response to 100 μM H2O2 was to 
determine the extent of protein carbonyl formation. The protein carbonyl data 
demonstrated that B9 cells formed fewer protein carbonyls over time in response to 
H2O2 than Jurkat cells (Figure 5.7). The level of protein carbonyls formed in B9 cells 
reached a maximum 1 hour after H2O2 treatment (0.144 nM/mg + 0.031). In contrast, 
the Jurkat cells continued to form protein carbonyls over time, reaching a maximum 
five hours after treatment (0.440 nM/mg + 0.05).  
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Figure 5.7: Protein carbonyl formation in Jurkats and B9s treated with H2O2. 
Jurkat and B9 cells treated with 100 μM H2O2 were harvested periodically over time 
and kept at – 80°C.  Protein carbonyls were labeled with DNP and adsorbed to a 
high-bind microtitre plate. Protein carbonyls were detected by ELISA using a 
streptavidin-conjugated HRP detection system. Values represent the mean + SE of at 
least 3 independent experiments. 
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5.3.5  Effect of H2O2 on growth in Jurkat and B9 cells 
 
The adverse affects of oxidative stress have been shown to affect the proliferative 
capacity of cells (Finkel and Holbrook 2000). Having demonstrated that Jurkat cells 
overexpressing Bcl-2 fail to undergo apoptosis in response to H2O2 exposure (Chapter 
3), yet show signs of oxidative stress, it was of interest to investigate whether the 
damaged cells continued to proliferate. To address this, Jurkat and B9 cells were 
treated with 100 μM H2O2 and their long-term growth was assessed (Figure 5.8). The 
data demonstrated that when Jurkat cells were treated with H2O2, they progressively 
died, reaching the lowest concentration of viable cells after 3 days (0.11x106 cells + 
0.08). After 8 days, those surviving Jurkat cells had shown signs of proliferation. In 
contrast, when the B9 cells were treated with H2O2, they went into a temporary 
growth arrest for a 2-3 day period, without significant cell loss (consistent with Figure 
3.8). The growth-arrested cells were viable and metabolically active, requiring daily 
media change. At approximately 3-4 days, the cells began to proliferate again, albeit 
at a reduced rate to untreated cells.  
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Figure 5.8: Monitoring growth of Jurkat and B9 cells treated with H2O2 over time. 
The growth of treated Jurkat and B9 cultures was monitored daily by counting cells 
with a hemocytometer using the trypan blue exclusion assay. The culture medium was 
replaced daily to avoid overgrowth. Values represent the mean + SE of at least 4 
independent experiments. 
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5.3.6  Effect of H2O2 on genomic instability in Jurkat and B9 cells 
 
Having demonstrated that Jurkat cells overexpressing Bcl-2 survive and continue to 
grow after H2O2 exposure, it was of interest to determine whether the surviving cells 
showed signs of genomic instability. The cytokinesis-block micronuclei (CBMN) 
assay is a common method used to detect chromosome breakages in lymphocytes 
exposed to genotoxic stress (Fenech et al. 1999; Fenech 2000, 2002). Micronuclei, 
also known as Howell-Jolly bodies to haematologists (Hutchison and Fergusonsmith 
1959), are chromosomal fragments resulting from chromosome breakages that cannot 
migrate to the spindle poles during mitosis (Hogstedt et al. 1981; Fenech 2002). Jurkat 
and B9 cells were exposed to H2O2 for four hours before being treated with the 
microfilament assembly inhibitor chytochalasin B, which blocks replicating 
mammalian cells in telophase, for a further 24 hours. The binucleated cells that 
resulted from chytochalasin B treatment were examined microscopically to detect 
chromosomal breakages (micronuclei formation) caused by H2O2 exposure (Figure 
5.9). 
 
The CBMN data revealed that Jurkat cells exhibited a very low basal level of 
micronucleated cells in control conditions; however, the number substantially 
increased after treatment with 50 μM H2O2 (Figure 5.10). Jurkat cells exposed to 
100 μM H2O2 became apoptotic or necrotic, making micronucleated cell counts 
unfeasible. Strikingly, B9 cells showed a dramatic increase in the amount of 
micronucleated cells in both basal conditions and following treatment with H2O2. B9 
cells exposed to 100 μM H2O2 expressed an extremely high level of micronucleated 
cells (~3.5%).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 5   
    
 
 
 
 
 
 
 
 
 
 
 
 
Binucleated 
cells 
Binucleated cells 
with micronuclei
 
 
Figure 5.9: Illustrative photographs of cells used for CBMN scoring. Photos are 
representative of at least 3 independent experiments. The photos show examples of 
binucleated cells (dividing cells) and binucleated cells with micronuclei (dividing 
cells harboring chromosomal breakages).  
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Figure 5.10: Micronuclei formation in Jurkat and B9 cells treated with H2O2. 
Histogram of MN formation in Jurkats and B9 cells treated with 50 μM and 100 μM 
H2O2. Treated cells were harvested and transferred to a glass slide by 
cytocentrifugation. MN were scored using criteria as previously described (Fenech et 
al. 2003). Values represent the mean + SE of at least 3 independent experiments. * 
Indicates a significant difference (p<0.05) between variables as determined by a One 
Way Repeated Measures ANOVA with Bonferroni multiple comparison (SigmaStat). 
 
 
 
5.4   Discussion 
 
The results from this study clearly show that Jurkat cells overexpressing Bcl-2 suffer 
the same extent of lipid peroxidation in response to H2O2 as the parental cell line. 
These results are in accordance with a study by Lee and coworkers (Lee et al. 2001) 
and suggest that Bcl-2 overexpression does not enhance lipid antioxidant or repair 
systems in Jurkat cells. The use of the C-11 BODIPY probe to detect lipid 
peroxidation has been validated in an extensive study by Drummen et al. (Drummen 
et al. 2002). Interestingly, several of the conflicting reports that suggest Bcl-2 
overexpression can prevent lipid peroxidation, including the original study by 
Hockenbery and colleagues, detected differences at later time-points (Hockenbery et 
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al. 1993; Tyurina et al. 1997). Differences seen at such time-points need to be 
interpreted with caution, as the induction of apoptosis can generate oxidants 
(Zamzami et al. 1995; Polyak et al. 1997; Chandra et al. 2000) that may obscure real 
differences seen due to antioxidant properties of Bcl-2. For example, Cai and Jones 
(Cai and Jones 1998; Cai et al. 1998) have shown that cytochrome c, released from 
the mitochondria of apoptotic cells, can cause an increase in the production of 
superoxide. In the same study, Bcl-2 inhibited superoxide production by maintaining 
cytochrome c in the mitochondria. This work highlights that Bcl-2 can appear to 
possess antioxidant properties by virtue of regulating the apoptotic pathway. In 
addition to ROS production, apoptosis is often accompanied by a depletion of the 
thiol reductant glutathione via oxidation (Macho et al. 1997) or efflux (van den 
Dobbelsteen et al. 1996; Pullar and Hampton 2002). The loss of glutathione during the 
early stages of apoptosis can leave the cell susceptible to oxidative damage (Hall 
1999).  
 
Protein carbonyl formation was also examined in H2O2 treated Jurkat cells 
overexpressing Bcl-2. The elevated level of oxidants produced during apoptosis may 
explain why the concentration of protein carbonyls continued to increase in Jurkat 
cells at later time-points. At these time-points (3-5 hr), Jurkat cells treated with 100 
μM H2O2 were beginning to exhibit apoptotic morphology. Protein carbonyl 
formation was comparable in both cell lines at early time-points, suggesting that the 
initial oxidant exposure caused a similar level of protein oxidation in Jurkat cells 
overexpressing Bcl-2.  
 
An alternative explanation is that cells overexpressing Bcl-2 may dispose of protein 
carbonyls more efficiently. Previous studies have shown that protein carbonyls 
formed by H2O2 exposure are effectively removed by the proteasome (Sitte et al. 
1998). Interestingly, Lee et al. (Lee et al. 2001) have recently demonstrated that cells 
overexpressing Bcl-2 have a higher proteasomal activity. Therefore, it is possible that 
the low level of protein carbonyls seen in cells overexpressing Bcl-2 is a reflection of 
the enhanced proteasomal activity, as opposed to any antioxidant properties of Bcl-2. 
This would be of interest for further investigation. 
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The overexpression of Bcl-2 had no effect on the level of oxidised GAPDH or 
peroxiredoxin thiols following exposure to H2O2. The pattern of thiol oxidation seen 
in the IAF-labeled gels was similar to that seen by Baty et al. (Baty et al. 2005), with 
the prominent GAPDH band becoming oxidised at low levels of H2O2. GAPDH thiols 
were oxidised in a time and dose-dependent manner in both cell lines. To the best of 
my knowledge this was the first time peroxiredoxin overoxidation has been examined 
in cells overexpressing Bcl-2. In support of previous studies, our results clearly 
showed that peroxiredoxin 2 was completely overoxidised in response to 100 μM 
H2O2 and is not immediately regenerated within the first hour of exposure (Rabilloud 
et al. 2002; Chevallet et al. 2003; Woo et al. 2003a; Woo et al. 2003b). 
 
Jurkat cells overexpressing Bcl-2 showed very distinct differences in cell growth after 
H2O2 exposure when compared with control cells.  Jurkat cells exposed to 100 μM 
H2O2 progressively died; however, Jurkat cells overexpressing Bcl-2 became 
temporarily growth-arrested before continuing to proliferate. Previous studies have 
demonstrated that the dose of H2O2 is critical in the cells decision to either undergo 
growth arrest or apoptosis (Davies 1999). The overexpression of Bcl-2 appears to bias 
the cells decision, blocking apoptosis and therefore promoting alternative stress 
responses, such as temporary growth arrest. It is possible that in the growth-arrested 
state, cells overexpressing Bcl-2 repair oxidative damage and they re-enter the cell 
cycle.  
 
This study demonstrated, for the first time, that the overexpression of Bcl-2 enhances 
the proportion of micronucleated cells seen in Jurkat cells following H2O2 exposure. 
The results attained by exposing Jurkat cells to H2O2 are very similar to those reported 
previously by Fenech et al. (Fenech et al. 1999). The fact that Bcl-2 increased the 
proportion of micronucleated cells is consistent with a previous study demonstrating 
that cells overexpressing Bcl-2 have a higher frequency of micronuclei formation 
following X-irradiation (Taga et al. 2000). These findings are also in accordance with 
the results of several other groups investigating the effect of Bcl-2 on oxidant-
mediated mutagenesis (Steinman 1995; Cherbonnel-Lasserre et al. 1996a, 1996b; 
Cherbonnel-Lasserre and Dosanjh 1997; Kuo et al. 1999; Saintigny et al. 2001). Such 
studies have consistently found that Bcl-2 overexpression enhances DNA and 
chromosomal damage, promoting mutagenesis in cells exposed to an oxidative insult. 
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Our findings are in line with a number of elegant in vivo studies showing that 
transgenic mice overexpressing Bcl-2 are prone to cancer and chromosomal instability 
(Reed et al. 1988; Strasser et al. 1990; McDonnell and Korsmeyer 1991; Gibbons et 
al. 1999; Letai et al. 2004; Oltersdorf et al. 2005). The data reported herein 
demonstrate that by overriding apoptosis, Bcl-2 perturbs the physiological 
surveillance of genomic instability and renders cells more susceptible to 
tumourigenesis.  
 
Bcl-2 not only enhances mutagenicity by suppressing apoptosis, it may also promote 
mutagenesis by elevating basal ROS production (Steinman 1995; Kowaltowski et al. 
2004) and impairing several DNA repair pathways (Liu et al. 1997; Zhan et al. 1999; 
Gu et al. 2001; Saintigny et al. 2001; La Thangue 2005; Youn et al. 2005). The 
overexpression of Bcl-2 suppresses the nucleotide excision repair pathway by 
downregulating the expression of key DNA glycosylase enzymes hOGG1 and hMYH 
(Liu et al. 1997; Gu et al. 2001). These enzymes are responsible for removing 
chemically altered DNA bases such as 8-oxo-dG. In addition, Bcl-2 overexpression 
inhibits the RAD51-dependent homologous recombination repair pathway (Zhan et al. 
1999; Saintigny et al. 2001). This pathway is fundamental in repairing DNA double 
strand breaks that might result from oxidant exposure. Overexpression of the Bcl-2 
mutant G145ABcl-2, which is defective in binding to BH3 proteins (Huang et al. 1997), 
inhibits the RAD51 recombination pathway (Saintigny et al. 2001), demonstrating 
that the anti-apoptotic properties of Bcl-2 can be genetically separated from its 
inhibitory effect on the RAD51 recombination pathway. Recent studies have shown 
that Bcl-2 overexpression also suppresses hMSH2, a DNA mismatch repair enzyme 
involved in repairing lesions in DNA (La Thangue 2005; Youn et al. 2005). 
Collectively, these studies reveal that Bcl-2 overexpression can suppress DNA repair 
pathways resulting in a mutator phenotype. It is likely that the Bcl-2-dependent 
decrease in DNA repair activity is a contributing factor in the oxidant-mediated 
mutagenesis of cells overexpressing Bcl-2. 
 
In summary, the results of this chapter have clearly demonstrated that Jurkat cells 
overexpressing Bcl-2 exhibit the same level of oxidative damage to lipids, protein and 
DNA as the parental Jurkat cells in response to H2O2 exposure. Furthermore, H2O2-
treated Jurkat cells overexpressing Bcl-2 continued to proliferate, despite damage to 
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cellular constituents. The inability of Jurkat cells overexpressing Bcl-2 to undergo 
apoptosis meant that they were more susceptible to genomic instability as a result of 
H2O2 exposure.  
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Chapter 6: Summary and Future Directions 
           
    
 
6.1. Summary of Findings 
 
The oxidant H2O2 can participate in a variety of damaging reactions with cellular 
constituents (Finkel and Holbrook 2000) that can activate apoptosis and necrosis 
(Chandra et al. 2000; Zong and Thompson 2006). The apoptotic pathway of cell death 
can be blocked by overexpression of the oncoprotein Bcl-2 (Green and Kroemer 
2004). Some investigators believe that Bcl-2 possesses antioxidant properties that 
protect cells from apoptosis in response to oxidants (Kowaltowski and Fiskum 2005). 
In this study, we investigated the cytotoxic and damaging properties of H2O2 in Jurkat 
cells overexpressing Bcl-2. In particular, we investigated whether the overexpression 
of Bcl-2 provides any protection against H2O2.  
 
We have shown that Jurkat cells exposed to H2O2 undergo apoptosis or necrosis 
depending on the dosage; intermediate doses favour apoptosis, while higher doses 
promote necrosis. The overexpression of Bcl-2 prevented cell death at the apoptotic 
doses, but not the necrotic doses of H2O2. However, inhibiting apoptosis with the pan-
caspase inhibitor z-VAD.fmk could not provide the same level of resistance against 
H2O2-induced cell death as Bcl-2 overexpression.  
 
These studies spurred investigations into whether Bcl-2 acted in an antioxidant 
capacity to prevent H2O2-induced cell death. The antioxidant systems of Jurkat cells 
overexpressing Bcl-2 were examined in detail. A number of Jurkat clones 
overexpressing Bcl-2 were used so that any differences seen could be correlated to the 
level of Bcl-2 expression. The intention was to build on the substantial body of 
literature suggesting that Bcl-2 enhances the antioxidant capacity of the cell 
(Hockenbery et al. 1993; Ellerby et al. 1996; Schor and Kagan 1997; Lee et al. 2001; 
Kowaltowski et al. 2004). There were no significant differences; however, among the 
Bcl-2 transfectants in any of the antioxidant enzymes. Together, this data suggested 
Chapter 6                                                                                                                    
                               
that Jurkat cells overexpressing Bcl-2 decomposed oxidants such as H2O2 no better 
than the parental Jurkat cells.   
  
Consistent with this observation, Jurkat cells overexpressing Bcl-2 exhibited the same 
level of oxidative damage to cellular constituents in response to H2O2 exposure as the 
parental Jurkat cells. Interestingly, damaged Jurkat cells overexpressing Bcl-2 that 
failed to undergo apoptosis continued to proliferate after a period of temporary growth 
arrest. We also found that Jurkat cells overexpressing Bcl-2 were more susceptible to 
genomic instability as a result of H2O2 exposure.   
 
 
6.2. Future directions 
 
Although our studies have systematically demonstrated that Bcl-2 does not enhance 
the antioxidant capacity of Jurkat cells, it may behave in a more subtle manner, 
altering the redox environment in such a way as to promote cell survival. There are 
numerous examples in the literature of signaling proteins that are regulated by slight 
changes in cellular redox (Cross and Templeton 2004). Many of these proteins 
possess reactive cysteine residues that are sensitive to oxidation (Forman et al. 2004). 
It would be of interest to examine whether Bcl-2 overexpression predisposed thiol 
redox sensors to remain in the reduced form. Such alterations would not be detectable 
in the global assays performed thus far; however, they may be detected using the 
oxidised thiol proteomics methodology established in our lab by Baty et al. (Baty et 
al. 2002, 2005). This method enables the identification of low abundance thiol 
proteins that are sensitive to oxidation.  
 
The fact that Bcl-2 overexpression enhanced the mutagenicity of H2O2 in Jurkat cells 
is of special interest and warrants further investigation. It would be of interest to 
examine whether the Jurkat cells overexpressing Bcl-2 treated with H2O2 exhibit 
persistant genomic instability. For instance, it would be interesting to see if B9 cells 
exposed to H2O2 retain a higher proportion of micronucleated cells after longer time 
periods, greater than a week. Furthermore, it may be constructive to investigate the 
mutagenic effect of Bcl-2 overexpression in a primary cell line exposed to H2O2. Such 
studies would be amenable to comparative global hybridization (CGH), which might 
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enable the identification of common chromosomal abnormalities that occur in 
response to H2O2 exposure. Based on the findings, it seems likely that the 
overexpression of Bcl-2 will render cells more susceptible to mutagenesis imposed by 
other oxidants. Indeed, Kuo et al. (Kuo et al. 1999) have demonstrated that Bcl-2 
overexpression enhances mutagenesis imposed by benzene metabolites, which are 
known to generate ROS. It may also be of interest to investigate the potential role that 
suppressed DNA repair (Liu et al. 1997; Zhan et al. 1999; Saintigny et al. 2001; Youn 
et al. 2005) plays in enhancing the mutagenesis of Jurkat cells overexpressing Bcl-2.  
 
In conclusion, the results presented herein provide useful insights into the effect that 
Bcl-2 overexpression has in protecting Jurkat cells from the cytotoxic action of H2O2. 
The results attained in this thesis, showing the cytoprotective effect of Bcl-2 in Jurkat 
cells exposed to H2O2, provide a platform for exciting research in the future.  
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